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ABSTRACT
Resistance to flavivirus-induced disease is conferred by a single gene that encodes
oligoadenylate synthetase (Oas) 1b (Oas1b). Oas1b is not a functional synthetase suggesting its
anti-flavivirus mechanism is RNase L-independent and that it may be mediated by interactions
with other host cell protein(s). A yeast two-hybrid screen was used to identify host cell binding
partners of Oas1b. Candidate partners were confirmed by yeast co-transformation and coimmunoprecipitation analyses. Oxysterol binding protein-related 1L (ORP1L) and ATP binding
cassette subfamily F 3 (ABCF3) were found to interact with Oas1b. RNAi knockdown studies
suggested that ORP1L and ABCF3 form a tripartite complex with Oas1b that is critical for the
flavivirus-induced disease resistance mechanism.

Stresses including oxidation, nutrient starvation, and viral infections often induce the
formation of stress granules (SGs) in eukaryotic cells. In response to stress, eIF2α kinases
phosphorylate eIF2α leading to stalled 48S pre-initiation complexes and SG formation. West
Nile virus (WNV) Eg101 infections were previously shown not to induce the formation of SGs.
Infections with viruses of other natural WNV strains, as well as a WNV lineage 1/2-based
infectious clone (W956IC) were analyzed and only W956IC infections were found to induce
SGs. eIF2α kinase knockout MEFs were used to show that the W956IC-induced SGs were PKRdependent. WNV chimeras were made by inserting Eg101 genes into the W956IC backbone.
Chimeras replacing NS5 or NS1 and NS5 or NS1 and NS3 and NS4a reduced SG formation as
well as early viral RNA synthesis similar to Eg101 infections. W956IC infections but not Eg101
infections were shown to produce exposed viral dsRNA at early times after infection. The data
suggest that natural WNV infections evade the cell SG response by suppressing the amplification
of viral RNA until cytoplasmic membranes have been remodeled to protect replication
complexes from detection.
It was previously reported that WNV Eg101 infections inhibited the formation of
arsenite-induced SGs. The ability of other natural WNV strain infections to inhibit SG formation
by arsenite (HRI), DTT (PERK), W956IC co-infection (PKR), and heat shock treatments was
assessed. WNV infections only inhibited arsenite-induced SG formation suggesting that WNV
infections specifically suppress the response to oxidative intermediates.

INDEX WORDS: West Nile virus, 2′-5′ Oligoadenylate synthetase 1b (Oas1b), Oxysterol
binding protein-related protein 1L (ORP1L), ATP binding cassette subfamily F 3 (ABCF3),
Small hairpin RNA (shRNA), Stress granule, eIF2α, PKR, Chimera.
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CHAPTER 1
INTRODUCTION
Classification and Clinical Significance of Flaviviruses
The family Flaviviridae contains three genera, Flavivirus, Pestivirus, and Hepacivirus,
and the unclassified hepatitis G viruses. The genus Flavivirus consists of about 60 viruses and
includes human pathogens such as dengue virus (DEN), yellow fever virus (YFV), Japanese
encephalitis virus (JEV), and West Nile virus (WNV) (Lindenbach, 2007). West Nile virus was
first isolated in Uganda in 1937 and the majority of the more than 70 strains have been classified
into two distinct lineages based on sequence homology. Lineage 1 WNV strains are endemic in
northern Africa, Europe, India, the Middle East, Asia and North America, while lineage 2 WNV
strains are typically found in sub-Saharan Africa (Bakonyi et al., 2006; Hayes et al., 2005;
Knipe, 2007; Lanciotti et al., 2002). As of late 2006, the Centers for Disease Control (CDC) had
reported over 23,000 cases of human WNV infection within the United States (Sejvar, 2007).
WNV is arthropod-borne and its transmission cycle in nature is usually between Culex
mosquito species and birds; however, transmission of WNV to horses and humans by mosquitoes
occurs occasionally (Brinton, 2002). WNV infectious particles present in the salivary glands of
infected mosquitoes are transmitted to vertebrate hosts during a blood meal. Initially, the virus
replicates at the site of infection and then moves to the regional lymph nodes. Once in the lymph
nodes, the virus can disseminate into the vascular system, spread to peripheral organs and in
some cases, cross the blood brain barrier. WNV is part of the Japanese encephalitis serocomplex
and is known to attack the central nervous system, particularly the medulla of the brainstem
(Brinton, 2002). WNV infection usually produces asymptomatic or mild disease with symptoms
that can include fever, headache, body rash, muscle fatigue, and disorientation (Brinton, 2002).
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About 1 in 150 or fewer infected individuals develop more severe diseases such as encephalitis,
hepatitis and polio-like syndromes (Brinton, 2002). The infection usually clears within about 3-6
days; however, about 10% of those with severe illness can have a fatal outcome with older and
immunocompromised individuals having a higher incidence of mortality.

Flavivirus Replication Cycle
WNV replicates in a wide range of cell cultures including primary chicken, duck, and
mouse embryo cells and continuous cell lines from monkeys, humans, pigs, rodents, amphibians,
and insects (Brinton, 1986). The life cycle of flaviviruses occurs entirely within the cytoplasm of
infected cells (Figure 1.1). Entry of the virion into cells is mediated through the interaction of the
E protein with an unknown receptor(s). The virion is endocytosed at clatherin-coated pits,
transported to prelysosomal vesicles, and low pH-induced fusion of the virion and vesicle
releases the viral nucleocapsid (Chu et al., 2006; Chu and Ng, 2004; Heinz and Allison, 2000;
Heinz et al., 2004). After release, the viral genome acts as a messenger RNA (mRNA) and
immediately begins translation of the single open reading frame (ORF) to produce the viral
polyprotein. The viral polyprotein is cleaved co- and post-translationally by both cellular and
viral proteases (Lindenbach, 2007). Replication of the viral genome occurs within vesicular
invaginations of the ER membrane that open to the cytoplasm through a small pore (Kim et al.,
2004; Welsch et al., 2009). The nascent viral genomic RNA exits these vesicle structures and is
either translated by neighboring ribosomes or bound to capsid proteins attached to opposing ER
membrane which also contain viral envelope (E) and membrane (prM) proteins. The capsid
protein encapsidates the viral genome and produces the immature virion within the lumen of the
ER (Welsch et al., 2009). Immature virions traverse the ER and trans-Golgi network,
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Figure 1.1. Flavivirus Replication Cycle. (A) Virion attachment, entry, and fusion and
uncoating of the viral genome RNA. (B) Translation of the viral RNA. (C) Proteolytic
processing of the viral polyprotein into the individual viral proteins. D) Synthesis of the
complementary viral minus strand RNA. (E) Synthesis of the genome RNA from the template
minus strand RNA. (F) Encapsidation and assembly of immature virions in the ER. (G)
Processing of prM to M to produce mature virions in the trans-Golgi network. (H) Fusion of
virion-containing vesicles and the plasma membrane resulting in release of infectious virus
particles from the cell. Modified figure and legend adapted from (Brinton, 2008).
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concurrently maturing via the cleavage of prM to M (Plevka et al., 2011). Mature virions are
approximately 50 nm in diameter, spherical and enveloped. WNV virions are transported in
vesicles to the plasma membrane and released by fusion of the vesicle with the plasma
membrane (Brinton, 2002).

Flavivirus Genome
The flavivirus genome is a positive-sense, single-strand RNA (+ssRNA) with a capped 5'
end but no 3' poly (A) tail. Flavivirus genomes are unique among mammalian positive-sense
RNA viruses in the lack of a 3' poly (A) tail (Brinton, 2002). The flavivirus genome is about 11
kb in length and contains one open reading frame that encodes three N-terminally located viral
structural proteins, capsid (C), membrane (prM/M), and envelope (E), followed by seven Cterminal nonstructural proteins, NS1, NS2a, NS2b, NS3, NS4a, NS4b, and NS5 (Figure 1.2)
(Brinton, 2002). The ten mature viral proteins are generated via proteolytic processing of the
polyprotein by both viral and cellular proteases (Brinton, 2002). The majority of the
nonstructural proteins are multi-functional and all seven appear to be involved in viral RNA
synthesis (Brinton, 2002; Mackenzie et al., 1996).

Structural Proteins
WNV virions are ~50 nm in diameter, spherical and enveloped. They are made up of
three structural proteins: E, prM/M and capsid (C). The E and M proteins compose the exterior
surface of the virion (Lindenbach, 2007). The E glycoprotein is required for receptor recognition
and fusion of the virion for entry into cells; however, the cellular protein used as the WNV entry
receptor has yet to be determined. Immature virions have trimers of prM and E heterodimers on

5

Figure 1.2. Schematic representation of the WNV polyprotein. The WNV genome is
translated into a single polyprotein that is processed co- and post-translationally by both host and
viral proteases into 10 viral proteins. Three structural proteins (E, prM/M, and C) are encoded in
the N-terminus while seven nonstructural proteins (NS1, NS2a, NS2b, NS3, NS4a, NS4b, and
NS5) are encoded in the C-terminus. Figure and modified legend adapted from (Brinton, 2002).
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their surface that create spikes. The M protein is cleaved from prM by the host protease furin in
the trans-Golgi network, which leads to a conformational change and rearrangement of the E
proteins so that they lie flat against the envelope and form an icosahedrom shell on the outside of
the virion (Kuhn et al., 2002).
The mature virion particles that contain a smooth surface with icosahedral symmetry
made up of 90 head-to-tail homodimers of E (Brinton, 2008; Kuhn et al., 2002). The virion
capsid is about 30 nm in diameter and has no discernable geometric symmetry inside virions.
RNA-binding domains (RBD) are found at both the N- and C-termini of the C protein and are
separated by a hydrophobic domain that tethers the protein to the lipid bilayer membrane.
Flavivirus-infected cells have been reported to release non-infectious virus-like particles (VLPs)
that are composed of the E and M proteins but lack capsid and viral RNA (Ferlenghi et al., 2001;
Takahashi et al., 2009). These data suggest that C dimers are essential for the recruitment of viral
RNA for the formation of infectious virions; however, no encapsidation signal has yet been
identified in the genome RNA (Brinton, 2008). The C dimers have very high net positive
charges, suggesting that the interaction between C dimers and the viral genomic RNA is
nonspecific.

Viral Nonstructural Proteins (NS)
The WNV genome encodes seven nonstructural proteins, NS1, NS2a, NS2b, NS3, NS4a,
NS4b and NS5. Each of these viral nonstructural proteins is suggested to be required for
replication of the viral genome; however, the precise function(s) of each of these proteins within
viral replication complexes is not known.
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The WNV NS1 protein is a ~46 kDa glycoprotein that localizes to the ER membrane and
cell surface, and is secreted from infected cells (Avirutnan et al., 2011; Brinton, 2008; Falgout
and Markoff, 1995; Smith and Wright, 1985; Somnuke et al., 2011; Wilson et al., 2008). A
correlation between the levels of secreted NS1 in the blood and disease severity has been
observed in a hamster model (Macdonald et al., 2005). Secreted NS1 proteins from different
flavivirus members have been reported to attenuate the antimicrobial complement pathway by
directly binding to various complement proteins including regulatory protein H, C4, C4b binding
protein and C1s (Avirutnan et al., 2011; Chung et al., 2006; Somnuke et al., 2011). For example,
NS1 binding to regulatory protein H inhibits complement activation and decreases the deposition
of complement attack complexes on infected cells (Chung et al., 2006). Secreted NS1 has also
recently been reported to inhibit the establishment of an antiviral state by blocking TLR3mediated activation of IFN regulatory factor 3 and production of interleukin 6 (Wilson et al.,
2008). The precise intracellular functions of NS1 are currently unknown; however, it has been
suggested to be involved in virus replication and has been reported to co-localize with viral
replication complexes, likely through interactions with NS4a (Lindenbach and Rice, 1999;
Mackenzie et al., 1996). Studies delivering NS1 protein by trans-complementation resulted in the
recovery of virus containing a defective yellow fever virus genome and the recovery of these
trans-complemented viruses suggested a role for NS1 in the initial synthesis of the viral minus
strand RNA (Lindenbach and Rice, 1997). The NS1 protein contains two or three N-linked
glycosylation sites and studies have shown that there is a reduction in viral RNA synthesis when
these sites are mutated (Muylaert et al., 1996). Within the Japanese encephalitis virus serogroup
of flaviviruses, a longer NS1 protein, referred to as NS1′, is produced. NS1′ is suggested to form
by the presence of a slippery sequence near the NS1-NS2a junction that causes a -1 ribosomal
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frameshift to occur due to a downstream psuedoknot structure (Melian et al., 2010). NS1′ was
suggested to function in viral neuroinvasion by studies showing that removal of the pseudoknot
structure inhibited the production of NS1′ and mice subsequently injected intraperitoneally with
the virus produced greater than 80% survivial of encephalitis compared to mice injected with
wildtype virus (Melian et al., 2010).
Infected cells contain both a ~22 kDa full length NS2a protein and a C-terminally
truncated ~20 kDa protein (Chambers et al., 1990a; Nestorowicz et al., 1994). Again, the precise
function(s) of NS2a in flavivirus replication is unknown but it is suggested to be a
transmembrane protein that is involved in virus assembly and has been reported to localize with
replication complexes and interact with NS3, NS5 and the 3′ UTR (Kummerer and Rice, 2002;
Lindenbach, 2007; Mackenzie et al., 1998). NS2a was also shown to act as a suppressor of
interferon-β (IFN-β) signaling when it was exogenously expressed in cells infected with
Newcastle disease virus (NDV) and rescued the replication of the IFN-sensitive NDV (MunozJordan et al., 2003). The ~14 kDa NS2b protein is also membrane associated. Currently, NS2b
has only been identified as a cofactor of NS3 required for viral polyprotein processing
(Lindenbach, 2007). Both NS2a and NS2b are suggested to be transmembrane proteins that aid
in anchoring the soluble viral NS3 protease to the replication complex.
The ~70 kDa flaviviral NS3 protein possesses numerous enzymatic functions. NS3
functions as the viral serine protease and this activity is contained within an N-terminal domain
of NS3. NS2b functions as a cofactor for the NS3 protease activity (Bessaud et al., 2006;
Chambers et al., 1990b; Miller et al., 2006). The NS2b-NS3 protease complex cleaves the
NS2a/2b, NS2b/NS3, NS3/NS4a, and NS4b/NS5 junctions of the viral polyprotein (Assenberg et
al., 2009; Brinton, 2008; Lindenbach, 2007). The remainder of the NS3 sequence contains
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homologies to RNA helicase, nucleoside triphosphatase (NTPase), and RNA triphosphatase
(RTPase) motifs. The RNA helicase domain is a supergroup 2 RNA helicase (Gorbalenya et al.,
1989) and is proposed to hydrolyze ATP to unwind the secondary structures of the viral RNA
(Wengler, 1991, 1993). Mutational studies specifically abolishing the RNA helicase activity of
NS3 further confirmed the necessity of the functionality of this domain for virus growth
(Matusan et al., 2001). The C-terminal RTPase domain is proposed to dephosphorylate the 5′ end
of the genome to allow capping (Wengler, 1993). When overexpressed alone, the flavivirus NS3
protein induces apoptosis in a pathway involving both caspases-8 and -3; however, this is not the
case during an infection. NS3 also contains the main antigenic peptide determinant of MHC
class-II molecules important for the antiviral CD8+ cytotoxic T cell response (Lobigs et al.,
1994; Ramanathan et al., 2006).
NS4a (~16 kDa) and NS4b (~27 kDa) are both small hydrophobic proteins and are
connected by a 2K peptide. The precise function(s) of these proteins in viral replication is
currently unknown but both have been shown to colocalize with the viral replication complexes
(Mackenzie et al., 1998; Miller et al., 2006). The 2K peptide is removed by both host and viral
proteases and a mutation at the 9th residue (Val to Met) of the 2K peptide has been reported to
confer resistance to lycorine, a flavivirus inhibitor, as well as rescuing viral growth in Oas1bexpressing cells (Mertens et al., 2010; Zou et al., 2009). It has been reported that the cleavage of
the 2K peptide is an important step for membrane rearrangement, likely essential for replication
complex formation (Miller et al., 2007; Roosendaal et al., 2006). Overexpression of recombinant
NS4a protein alone was shown to induce membrane rearrangement that slightly differed from
virus-induced membrane rearrangements, suggesting that NS4a is the main viral protein involved
in this function but other cell factors may also be involved in inducing membrane rearrangement
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during flavivirus infections (Roosendaal et al., 2006). Similar to NS2a, NS4a and NS4b were
both shown to act as IFN signaling antagonists, with NS4b being the most suppressive (MunozJordan et al., 2005; Munoz-Jordan et al., 2003). In addition, the co-expression of NS2a, NS4a
and NS4b was shown to completely inhibit IFN signaling (Munoz-Jordan et al., 2003).
NS5 is the largest flavivirus nonstructural protein (~103 kDa) and is also multifunctional,
containing both methyltransferase (MTase) and RNA-dependent RNA polymerase (RdRp)
activities. The N-terminus of NS5 contains extensive sequence homology to S-adenosylmethionine (SAM)-dependent MTases (Koonin, 1993). In vitro studies confirmed the MTase
activity by demonstrating that a purified MTase domain of NS5 could transfer methyl groups
from SAM to RNA substrates (Egloff et al., 2002). Mutagenesis studies showed that the MTase
activity was essential for flavivirus replication (Hanley et al., 2002). The RdRp of flaviviruses is
structurally similar to the RdRps of many other positive-strand RNA viruses (Brinton, 2008;
Koonin, 1991; Malet et al., 2007; Rice et al., 1985). Mutating amino acids in the highly
conserved GDD motif of the NS5 RdRp completely ablates RNA synthesis activity, confirming
the requirement of an intact RdRp domain for viral RNA replication (Kim et al., 2007). Other
functions have been identified for NS5 in addition to the MTase and RdRp activities. NS5
contains two nuclear localization signals and has been reported to localize NS5 to the nucleus of
infected cells depending on its phosphorylation status (Pryor et al., 2007). However, NS5 nuclear
localization has been shown to vary depending on cell type and virus strain. The mechanism
controlling NS5’s nuclear localization is unknown but it has been suggested to be involved in
regulating virus production as well as in mediating the antiviral response to infection by
regulating IL-8 production (Pryor et al., 2007). Similar to the NS2a, NS4a and NS4b, NS5 was
also shown to interfere with IFN signaling by binding to the intracellular side of IFN receptor
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complexes and inhibit the phosphorylation of downstream effector molecules, such as STAT1
(Best et al., 2005).

Host Genetic Resistance/Susceptibility to Virus-Induced Disease
Viruses are intracellular pathogens that must intimately interact with a host cell to
replicate. This interaction between host and virus is typically parasitic since viruses use host cell
machinery for synthesis of their products. This relationship is usually detrimental to the host
when a virus first infects a previously uninfected species. Viruses typically co-evolve with their
host over time and it is likely that many of the host species populations currently resistant to a
particular virus infection were selected due to virus-induced morbidity or mortality over time.
The interactions between host and virus are complex, commonly involving both the innate and
adaptive immune responses. However, resistance or susceptibility to virus-induced diseases can
sometimes be controlled by a single gene. There have been approximately 30 examples of this
phenomenon identified to occur naturally in mice and a few identified in humans (Lee et al.,
2003). Resistance genes are first identified when individuals of a given host species vary in their
response to infection with a single virus or members of a virus family. Mapping analyses are
subsequently used to identify the chromosome and then the gene(s) associated with the disease
response phenotype. There are three main stages of a virus infection at which host resistance
mechanisms have been shown to function: entry of viruses, intracellular stages of virus
replication, or recognition and destruction of infected cells by immune cells (Lee et al., 2003).
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Genetic Resistance due to Blocking Viral Entry
Host resistance to virus-induced disease is most commonly observed to occur at the stage
of virus entry into the cell and defines viral tropism. Examples of viruses for which this has been
shown to be the case are mouse hepatitis virus (MHV) and human immunodeficiency virus
(HIV) (Lee et al., 2003). Disease resistance to MHV is conferred by variation in Caecam1, the
MHV receptor. CEACAM1a is expressed in susceptible BALB/c mice while CAECAM1b is
expressed in resistant SJL/J mice (Tan et al., 2002). Differences in susceptibility were
determined to be due to a dramatic difference in MHV binding to these two receptors due to
substitutions at six residues in an exposed loop of the amino-terminal immunoglobulin-like
domain where the MHV spike proteins bind (Boyle et al., 1987; Dveksler et al., 1991; Ohtsuka et
al., 1996; Rao et al., 1997). An example of genetic resistance to virus-induced disease in humans
was observed during HIV-1 virus infections. Disease resistance is conferred in a subset of
individuals that express a 32 bp deletion in their CCR5 gene. CCR5 is a co-receptor for M-tropic
HIV-1 viruses (Berger et al., 1999; Dean et al., 1996; Liu et al., 1996; Samson et al., 1996;
Zimmerman et al., 1997). Individuals homozygous for this deletion are completely resistant to
M-tropic HIV-1 infections while heterozygous individuals display delayed progression to the
onset of AIDS (Berger et al., 1999; Dean et al., 1996).

Genetic Resistance due to Intracellular Effectors
Other host genetic resistance mechanisms are mediated intracellularly during viral
infections. Viruses that are affected by this type of genetic resistance include orthomyxoviruses
(i.e. influenza A virus and Thogoto virus), vesicular stomatitis virus (VSV), murine leukemia
virus and members of the genus Flavivirus (Lee et al., 2003). During influenza A virus
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infections, disease resistance in A2G mice is mediated by the product of the Mx1 dominant allele
(Haller and Kochs, 2002; Kolb et al., 1992). Susceptible mice, such as CBA/J and BALB/c, do
not express a functional Mx1 protein due to either a non-sense mutation or a large deletion
within the allele, respectively (Staeheli et al., 1988). The Mx1 protein is classified as a GTPase,
homologous to dynamin proteins and is localized within the cell nucleus. It was suggested that
the Mx1 protein of mice confers resistance to influenza A virus infections by binding the viral
polymerase and sequestering it to promyelocytic leukemia protein nuclear bodies, thereby
inhibiting replication of the virus (Geoffroy and Chelbi-Alix, 2011; Haller and Kochs, 2002;
Stranden et al., 1993). Mice also express an Mx2 protein that is localized to the cytoplasm. This
protein has been shown to inhibit the replication of viruses such as Thogoto virus (Haller and
Kochs, 2002). Mx2 proteins interact with Thogoto virus nucleocapsid proteins and prevent their
translocation into the nucleus which is required for virus replication (Haller and Kochs, 2002).
The human genome encodes MxA and MxB proteins. Only the MxA protein has been defined as
having antiviral activity (Haller and Kochs, 2002). In contrast to the mouse Mx1 and Mx2
proteins that function in separate compartments of the cell, the antiviral activity of human MxA
functions regardless of the intracellular location and affects numerous other viruses (Haller and
Kochs, 2002).
Some inbred mouse strains show differential susceptibility to flavivirus-induced disease
(Perelygin et al., 2002; Urosevic et al., 1999; Webster and Johnson, 1941). It was shown that an
allele of a single gene, Flv, conferred differential susceptibility specific to flavivirus infection in
mice and that resistance is inherited as a dominant Mendelian trait (Groschel and Koprowski,
1965; Sabin, 1952; Sangster et al., 1993; Sangster and Shellam, 1986). A positional cloning
approach identified Oas1b as the Flvr gene (Perelygin et al., 2002). When the resistant allele,
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Flvr, was subsequently "knocked in" to a susceptible mouse strain replacing the susceptible
allele, Flvs, the mice generated displayed the flavivirus resistance phenotype (Scherbik et al.,
2007a). These results proved that resistance/susceptibility to flavivirus-induced disease is
mediated by a single gene.
OAS proteins are upregulated by interferons that are produced in response to a viral
stimulus (Sarkar and Sen, 2004). Typically, the antiviral activity of OAS proteins is mediated by
the recognition of viral dsRNA during infection, which activates the OAS proteins to synthesize
2′-5′ linked oligo As (2-5 As) from ATP. The 2-5 As then activate latent RNase L to degrade
viral or cellular ssRNA, thereby inhibiting infection (Figure 1.3). Eight duplicated copies of the
Oas1 gene exist in mice (Oas1a-h) and are encoded in a 210 kb genomic region on chromosome
5; however, only Oas1a and Oas1g are functional synthetases (Kakuta et al., 2002). A full-length
Oas1b protein is expressed by the Flvr allele in resistant mice, while a truncated Oas1b protein is
expressed in susceptible mouse strains from the Flvs allele (Figure 1.4). The truncated form of
Oas1b (Oas1bt) is the result of a premature stop codon produced by a C820T transition within
the fourth exon, yielding a protein that is 30% shorter (Perelygin et al., 2002). Both the fulllength and truncated Oas1b proteins have a four amino acid deletion in their N-terminal P-loop
motif as well as a deletion in their C-terminal CFK motif. The CFK motif and the P-loop motif
are critical for 2-5 OAS activity and the CFK motif is essential for multimerization.

Genetic Resistance due to Recognition and Destruction by Immune Cells
Alleles that confer disease resistance are sometimes involved in the recognition and
removal of the virus by immune cells. Some examples of viruses that are susceptible to these
alleles include Friend leukemia virus and murine cytomegalovirus (MCMV) (Britt and Chesebro,
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1980; Farrell et al., 1997; Lee et al., 2003). In the case of MCMV, resistance is observed in
C57BL/6 mice and is mediated by the product of the Cmv1r allele, which encodes the Ly49H
activating receptor expressed by natural killer (NK) cells that can recognize the MCMV m157
antigen expressed on the surface of infected cells and mediate their killing (Brown et al., 2001;
Daniels et al., 2001; Lee et al., 2001). This is in contrast to susceptible DBA/2 mice that possess
the Cmv1s allele that does not encode the Ly49H receptor, but instead encodes the Ly49I
inhibitory receptor on NK cells that also recognizes and binds to m157 but does not result in
infected cell killing by NK cells (Arase et al., 2002). The m157 antigen mimics MHC class I
molecules and are recognized by Ly49I leading to inhibitory signaling that downregulates MHC
class I expression in infected cells (Adams et al., 2007). Due to these differences, resistant mice
are able to control the infection by removing the MCMV-infected cells through NK cell
mediated killing, whereas susceptible mice are unable to efficiently activate their NK cell
response to stop the MCMV infection, resulting in higher viral titers in infected mouse tissues
(Scalzo et al., 1990).
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Figure 1.3. Schematic representation of the OAS-RNase L innate immune response
pathway. (A) During RNA virus infections, (B) dsRNA is produced that is sensed by OAS
proteins. (C) Upon recognition of dsRNA, these OAS proteins synthesize short 2′ – 5′ linked
oligo As from ATP. (D) The oligo As activate latent RNase L, which can then degrade cellular
and viral RNAs, (E) thereby blocking cell and viral translation.
Modified figure and legend adapted from (Silverman, 2007).
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Figure 1.4. Schematic representation of full lenth and truncated Oas1b. Full length Oas1b is
generated from the Flvr resistance allele while truncated Oas1b (Oas1bt) is generated from the
Flvs susceptibility allele. Oas1bt is ~30% shorter due to a premature stop codon within the 4th
exon. Image adapted with permission from Dr. Husni Elbahesh.
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Stress Granules
Translation initiation starts with the formation of the 43S complex of the small 40S
ribosome subunit, eIF2-GTP-tRNAiMet, and eIF3 (Pestova et al., 2001). The 43S subunit then
associates with other initiation factors (i.e. eIF4F, eIF4A, eIF4B, eIF1A and poly A binding
protein) and scans the 5′ UTR of the mRNA until it locates the initiator codon and forms the 48S
pre-initiation complex (Anderson and Kedersha, 2002b). eIF2-bound GTP in the 48S preinitiation complex is then hydrolyzed by eIF5, resulting in the release of some initiation factors
and allowing the binding of the large 60S ribosomal subunit to produce the complete 80S
ribosome (Anderson and Kedersha, 2002b; Pestova et al., 2001). The 80S ribosome can then
continue the translation of the nascent protein by moving down the mRNA and allowing other
80S ribosomes to form at the beginning of the mRNA, creating a polysome. Environmental
stresses such as oxidation, UV irradiation, heat, and viral infection lead to the transient formation
of discrete cytoplasmic foci known as stress granules (SGs) (Anderson and Kedersha, 2002a,
2006, 2007, 2008; Emara and Brinton, 2007; Gilks et al., 2004; Kedersha and Anderson, 2002;
Kedersha et al., 2002; Kedersha et al., 1999). Stress granules were first discovered in chicken
embryo fibroblast cells maintained at 45ºC (Collier and Schlesinger, 1986). In response to stress,
the alpha subunit of eIF2 (eIF2α) is phosphorylated by one of four eIF2α kinases, protein kinase
R (PKR), PKR-related endoplasmic reticulum localized kinase (PERK), general control
nonrepressed 2 kinase (GCN2), or heme-regulated inhibitor kinase (HRI) (Anderson and
Kedersha, 2002a, 2008). Phosphorylation of the alpha subunit of the eIF2αβγ ternary complex
converts it to a competitive inhibitor of eIF2B and renders it unable to load initiator tRNAiMet to
the ribosome for the initiation of protein synthesis. The decreased amounts of available eIF2GTP-tRNAiMet then allows the binding of RNA-binding proteins such as T cell intracellular
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antigen 1 (TIA-1), TIA1-related (TIAR) or Ras GTPase-activating protein-binding protein
(G3BP) to 48S pre-initiation complexes (Gilks et al., 2004; Kedersha and Anderson, 2002).
These proteins can self aggregate to form SGs. Binding of these proteins to 48S pre-initiation
complexes leads to the stalling of mRNA translation (translational arrest) and results in
dissociation of the polysomes through run off of ribosomes (Figure 1.5A-C) (Anderson and
Kedersha, 2002a). However, global translation is not completely silenced since the translation of
stress-response proteins including the heat shock proteins still occurs (Anderson and Kedersha,
2008; Kedersha et al., 2002). Other components of SGs include translation initiation factors
(eIF4E, eIF3, eIF4A, and eIFG), PABP, and other RNA-binding proteins involved in mRNA
splicing, transcription, signaling and development (Anderson and Kedersha, 2007, 2008). In two
recent reviews by Anderson et al. (Anderson and Kedersha, 2006, 2008), lists of proteins shown
to co-localize to SGs by fluorescent microscopy are provided (Anderson and Kedersha, 2006,
2008). It is thought that numerous species of SGs exist with varying protein components and that
SGs are dynamic, rather than static in nature (Kedersha et al., 2000). Messenger RNAs
sequestered in SGs can subsequently either be released for reinitiation of translation (Figure
1.5D) or moved to processing bodies (PBs) for degradation (Figure 1.5E) (Anderson and
Kedersha, 2006, 2007; Beckham et al., 2007; Sheth and Parker, 2003).

Virus-Induced Stress Granule Formation
Virus infections can induce SG formation; however, not all virus infections induce the
formation of SGs. Formation of SGs during viral infections is typically mediated by PKR, which
senses double-stranded viral RNA, and/or by PERK, which is activated in response to the
accumulation of unfolded proteins in the ER. Many types of viruses induce the formation of SGs
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Figure 1.5. Canonical pathway for the formation of stress granules. (A-C) Once 48S preinitiation complexes stall, the polysomes begin to dissociate through ribosome run off and the
stalled pre-initiation complexes are then bound to SG-nucleating proteins such as TIA-1 and
TIAR forming SGs. (D) After recovery from stress, mRNAs bound in these SGs can reinitiate
translation. (E) If stress is not relieved, the mRNAs in SGs can be sent to processing bodies for
degradation. Modified figure and legend adapted from (Anderson and Kedersha, 2002a).
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but some also actively suppress SG formation (Ariumi et al., 2011; Dauber et al., 2011;
Dougherty et al., 2011; Hanley et al., 2010; Khong and Jan, 2011; Legros et al., 2011; Lindquist
et al., 2011a; Lindquist et al., 2011b; McInerney et al., 2005; Montero et al., 2008; Piotrowska et
al., 2010; Querec et al., 2009; Rojas et al., 2010; Simpson-Holley et al., 2011; White et al.,
2007). For example, infections with Semliki Forest virus (SFV) and some strains of reoviruses
shut down host translation and induce the formation of SGs. SGs form in SFV-infected cells but
SFV encodes a translation enhancer that works downstream of eIF2α phosphorylation and is
involved in disassembling SGs located in close proximity to the viral positive-sense genome
RNA, thus allowing the translation of SFV viral proteins but not most host proteins (McInerney
et al., 2005). Reovirus c8 and c87 strain infections inhibit host protein translation, whereas
infections by the Dearing reovirus stain do not. The inhibition of host protein translation during
c8 and c87 reovirus infections induces the formation of SGs but allows the selective translation
of reovirus proteins (Smith et al., 2006). The precise mechanism by which these reovirus strains
selectively translate viral proteins in the presence of SGs is unknown; however, it was reported
that the expression of ATF4, a transcription factor important for cellular recovery from stress,
was required for the increased replication efficiency of these strains (Smith et al., 2006).
Poliovirus infections have also been shown to induce the formation of SGs early after infection
(Dougherty et al., 2011; Mazroui et al., 2006; Piotrowska et al., 2010; White et al., 2007). As the
infection continues, SGs disassemble due to the cleavage of the SG protein G3BP by the viral 3C
protease (White et al., 2007). However, recent studies have shown that although G3BP-positive
SGs disassembled in poliovirus-infected cells, TIA-1-containing SGs did not disassemble
(Piotrowska et al., 2010). Recently, infection of BHK cells with the highly attenuated yellow
fever virus vaccine, YF-17D, was reported to efficiently induce the formation of SGs (Querec et

22
al., 2009). This is in contrast to previous studies done in our lab showing that infections by other
members of the genus Flavivirus, WNV and dengue virus, did not induce SGs and inhibited the
formation of SGs induced by oxidative stress (Emara and Brinton, 2007).
Although rotavirus infections have been reported to induce the phosphorylation of eIF2α
at early times after infection which leads to host cell shut off via the activation of PKR, SGs do
not form in these infected cells (Montero et al., 2008; Rojas et al., 2010). The mechanism by
which rotavirus infections prevent SG formation in infected cells is currently unknown, but
studies have shown that infected cells dramatically relocalize host SG proteins to different
compartments (i.e. poly A binding protein relocates from the cytoplasm to the nucleus)
suggesting the possibility that these proteins are being used for the benefit of virus replication
(Montero et al., 2008). Human T cell leukemia virus (HTLV)-1 infections have also been shown
to inhibit the formation of SGs (Legros et al., 2011). The HTLV-1 Tax protein was initially
described as a viral oncoprotein, but has also been shown to translocate from the nucleus to the
cytoplasm during different stresses of infected cells (Gatza and Marriott, 2006; Suzuki et al.,
1996). Studies showed that cytoplasmic Tax was capable of inhibiting the formation of SGs
during infection through its interaction with histone deacytelase 6 (HDAC6) (Legros et al.,
2011). The exact mechanism by which the Tax-HDAC6 interaction inhibits SG formation is
currently unknown but this study represents the first example of a virally encoded protein
responsible for specifically inhibiting SG formation in infected cells. Future studies will likely
identify other unique pathways utilized by viruses to inhibit SG formation during infection.

23
GOALS OF THIS DISSERTATION

Specific Aim 1: To identify and characterize unique cellular binding partners of Oas1b and
to analyze the involvement of selected Oas1b interaction partners in the West Nile virus
infection cycle.
Viruses use host cell proteins to facilitate their replication in infected cells. Resistance
specific to flavivirus-induced disease in mice is conferred by the Flv gene, which was identified
as the enzymatically inactive 2'-5' oligoadenylate synthetase 1b (Oas1b) (Scherbik et al., 2007a).
The only known antiviral activity associated with Oas proteins is through the activation of
RNaseL; however, Oas1b was shown to be a non-functional synthetase, suggesting that Oas1b
mediates its antiflaviviral activity through an OAS-RNaseL-independent pathway. Experiments
were proposed to identify cellular protein(s) interaction partners of Oas1b and to analyze the
function of those candidate proteins in the WNV replication cycle to gain insights about the
mechanism by which Oas1b specifically reduces the efficiency of flavivirus replication

Specific Aim 2: To analyze the formation of virus-induced stress granules during infection
of BHK cells with a WNV lineage 2-based infectious clone.
Previous work in the lab showed that infections with the natural WNV strain Eg101 do
not induce the formation of SGs in BHK cells (Emara and Brinton, 2007). However, recent
studies showed that infections with a chimeric WNV lineage 2/1 infectious clone (W956IC) did
induce the formation of SGs. Studies were performed to identify the kinase responsible for SG
formation in W956IC-infected cells and to analyze the mechanism of differential SG formation
by infections with natural WNV strains and W956IC.
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CHAPTER 2

Specific Aim 1: To identify and characterize unique cellular binding partners of Oas1b and
to analyze the involvement of selected Oas1b interaction partners in the West Nile virus
infection cycle.
INTRODUCTION
The genus Flavivirus consists of about 60 viruses and includes human pathogens such as
dengue virus, yellow fever virus, Japanese encephalitis virus, and West Nile virus (WNV)
(Lindenbach, 2007). West Nile virus was first isolated in Uganda in 1937 and has been endemic
in Africa, southern Europe, Australia, and southern Asia (Brinton, 2002). Recently, it emerged in
the United States with over 23,000 cases reported as of late 2006 (Brinton, 2008; Sejvar, 2007).
WNV is arthropod-borne and its transmission cycle in nature is usually between Culex mosquito
species and birds, but virus transmission to horses and humans by mosquitoes occurs
occasionally (Brinton, 2002). WNV infection of humans is usually asymptomatic but can
sometimes result in mild disease with symptoms such as fever, headache, body rash, muscle
fatigue, and disorientation (Brinton, 2002). About 1 in 150, or fewer, infected individuals
develop more severe diseases such as

encephalitis, meningoencephalitis, paralysis,

poliomyelitis-like paralysis or hepatitis (Brinton, 2002).
The flavivirus genome is a positive-sense, single-stranded RNA with a capped 5' end but
no 3' poly (A) tail. These features are unique among mammalian positive-sense RNA viruses
(Brinton, 2002). The 11 kb flavivirus genome encodes one open reading frame that contains
three N-terminal viral structural proteins, capsid (C), membrane (prM, M), and envelope (E),
followed by seven nonstructural proteins, NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5
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(Brinton, 2002). The ten mature viral proteins are generated by proteolytic processing of the
polyprotein by viral and cellular proteases (Brinton, 2002). The majority of the non-structural
proteins are multi-functional and all seven appear to be involved in viral RNA synthesis
(Brinton, 2002; Mackenzie et al., 1996).
The 2'-5' oligoadenylate synthetase (2-5 OAS)/RNase L pathway is one of the innate host
defenses against viral infections. OAS gene expression is up-regulated by interferons produced
by cells in response to a viral infection (Sarkar and Sen, 2004). Viral double-stranded RNA
(dsRNA) activates OAS causing it to polymerize adenosine triphosphate (ATP) into short 2'-5'linked oligomers (2-5A) (Justesen et al., 2000). These oligomers then bind to and activate latent
endoribonuclease L (RNase L) that is constitutively expressed in cells. Activated RNase L
cleaves viral and cellular single-stranded RNAs, thereby reducing viral translation (Kakuta et al.,
2002). Eight duplicated copies of the OAS1 gene (Oas1a-h) are clustered within a 210 kb
genomic region on mouse chromosome 5 (Kakuta et al., 2002). Previous breeding studies with
mice displaying differential susceptibility to flavivirus-induced disease showed that the alleles of
a single Mendelian dominant gene, Flv, controlled this phenotype (Webster and Clow, 1936;
Webster and Johnson, 1941). Oas1b was identified by a positional cloning strategy as the Flv
gene (Perelygin et al., 2002). A full-length Oas1b protein is expressed by the Flvr allele in
resistant mice, while a truncated Oas1b (Oas1bt) protein is expressed from the Flvs allele in
susceptible mice. The resistant allele, Flvr, was "knocked in" to a susceptible mouse strain,
C57BL/6 (B6), replacing the susceptible allele, Flvs, to generate C57BL/6-Oas1bKI (KI) mice
that display the flavivirus resistance phenotype (Scherbik et al., 2007a). Among the eight Oas1
genes in mice only Oas1a and Oas1g have been reported to be functional synthetases (Elbahesh
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et al., 2011a; Kakuta et al., 2002). Therefore, Oas1b does not mediate its antiviral activity
through the canonical OAS-RNase L pathway (Elbahesh et al., 2011a; Scherbik et al., 2006).
As one means of gaining insights into the mechanism by which Oas1b specifically
reduces the efficiency of flavivirus replication, cellular protein interaction partners of Oas1b
were identified and their involvement in the Oas1b-mediated flavivirus resistance mechanism
was analyzed. Results from the current study identified peptides from ORP1L and ABCF3 as
Oas1b interaction partners in a yeast two-hybrid analysis. These interactions were confirmed by
in vitro yeast co-transformation and co-immunoprecipitation assays, as well as by
immunoprecipitation studies in mammalian cells using full length proteins. RNAi knockdown of
ORP1L resulted in decreased replication of the flavivirus WNV as well as of other RNA viruses
and this effect did not require the presence of Oas1b. Knockdown of ORP1L was recently
reported to cause increased endosomal movement (Vihervaara et al., 2011) and this could
explain the observed effect on the replication of multiple viruses that enter cells by endocytosis.
Knockdown of ABCF3 increased WNV replication but not Sindbis virus replication and this
effect was only observed in Oas1b-expressing cells. The results provide new insights about the
Oas1b-mediated flavivirus resistance mechanism.

RESULTS
Identification of putative Oas1b binding partners in a yeast two-hybrid screen
Although Oas1b was identified as the only gene needed to confer resistance to flavivirusinduced disease in mice (Scherbik et al., 2007a), it was shown to mediate its flavivirus-specific
antiviral activity by an RNase L-independent mechanism (Elbahesh et al., 2011a; Scherbik et al.,
2006). A yeast two-hybrid screen was used to identify candidate cell protein Oas1b binding
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partners that might participate in the Oas1b-mediated anti-flaviviral mechanism. In initial
experiments, a pre-transformed Mouse Brain cDNA library was screened as described in
Materials and Methods against a full length Oas1b bait; however, no viable yeast colonies were
detected on the selection plates. Yeast two-hybrid screens are unable to detect interactions with
proteins containing a transmembrane domain that tethers them to cytoplasmic membranes
preventing their translocation to the nucleus to act as transcription factors (Iyer et al., 2005).
None of the members of the OAS family so far analyzed have previously been reported to have a
transmembrane domain. However, analysis of the Oas1b sequence using the PredictProtein
software (www.predictprotein.org) predicted a short transmembrane domain starting 23 amino
acids from the C-terminus (Figure 2.1A). To determine whether the predicted transmembrane
domain of Oas1b was able to tether it to a cytoplasmic membrane, a vector expressing a GSTtagged full length Oas1b protein was transiently transfected into BHK cells and the localization
of the protein was detected by confocal microscopy. Oas1b colocalized with the endoplasmic
reticulum (ER) marker calnexin, but not with the mitochondrial marker CoxIV (Figure 2.1B).
Oas1b was shown to remain localized to the ER after WNV infection of these cells (Figure
2.1B). In contrast, transient expression of a GST-tagged truncated Oas1b (GST-Oas1bt) or a
GST tag alone resulted in a diffuse protein distribution throughout the cell with no ER
colocalization (Figure 2.1B). These results confirmed the presence of a transmembrane tail on
the full length Oas1b protein that anchors Oas1b to the ER membrane. The sequence of the
Oas1b transmembrane domain was BLASTed against the GenBank database but no matches
were found. The origin of this domain and the mechanism by which it was acquired by Oas1b are
currently not known.
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Figure 2.1. Full length Oas1b contains a transmembrane domain that localizes it to the ER
membrane. (A) The full length Oas1b protein expressed in resistant cells is predicted to contain
a C-terminal transmembrane domain. The Oas1bΔTM truncation mutant lacks the C-terminal
transmembrane tail.. The truncated Oas1b (Oas1bt) expressed in susceptible cells is generated by
a premature stop codon in exon 4. (B) Plasmids expressing GST, GST-Oas1bt, or GST-Oas1b
were transiently transfected into BHK cells. Twenty-four hr later, cells were either mockinfected or infected with WNV Eg101 (MOI of 5) and at 24 hr after infection cells were fixed,
permeabilized, incubated with the indicated antibodies and analyzed by confocal microscopy.
Anti-GST antibody (green) detected GST-tagged Oas1b, anti-calnexin antibody (red) detected
ER, anti-CoxIV antibody (red) detected mitochondria and Hoechst (blue) stained nuclei.
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A C-terminally truncated Oas1b mutant consisting of amino acids 1-353 of full length
Oas1b and referred to as Oas1bΔTM (Figure 2.1A) was next cloned into the yeast two-hybrid
bait vector pGBKT7. When the Oas1bΔTM protein was used as the bait in a two-hybrid assay
with the Mouse Brain cDNA library, 23 unique candidate partner peptides were identified.
Interaction between each of these peptides and Oas1bΔTM was subsequently tested with yeast
co-transformation assays as described in Materials and Methods. Growth of colonies on double
selection media indicated that cells were co-transformed with both the bait and prey plasmids
and growth of colonies on the quadruple selection media indicated that the two peptides
interacted in yeast. Of the 23 putative peptide partners, an interaction with Oas1b was confirmed
for only eight by yeast co-transformation assay on quadruple dropout selection media (Table 1).
The protein origin of each of the putative peptide partners was predicted using a BLAST
analysis.

Co-immunoprecipitation of putative binding partners and Oas1b
Since yeast two-hybrid analyses can produce false-positive results, in vitro coimmunoprecipitation assays were used to further confirm that the putative peptide partners
interacted with Oas1bΔTM. Oas1bΔTM and each of the putative partners was in vitro
transcribed and translated in the presence of
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S-labeled methionine. Oas1bΔTM and one of the

putative partners were then incubated together for 1 hr at RT and interaction was assessed by coimmunoprecipitation as described in Materials and Methods. The in vitro translated Oas1bΔTM
had an N-terminal c-Myc tag and each of the putative partners had an N-terminal HA tag.
Oas1bΔTM co-immunoprecipitated with the oxysterol binding protein related protein 1L
(ORP1L) peptide as well as with the ATP binding cassette protein 3, subfamily F (ABCF3)
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Table 1. Oas1bΔTM Yeast Two-Hybrid Analysis Results.

Clone
No.

Putative Protein Partner

16-1
(169 aa)

OSBP-Related Protein 1L (Orp1L)

27-6-4
(214 aa)

Eukaryotic Elongation Factor 1a

42-3-5
(81 aa)

ATP-Binding Cassette subfamily f, member 3 (Abcf3)

49-2-2
(32 aa)

Heterogenous Nuclear Ribonucleoprotein

68a-2-3
(253 aa)

Microtubule-associated Protein 1A

84-1-2
(136 aa)

Nucleosome Assembly Protein 1-like 2

113-1
(223 aa)

Cytochrome C Oxidase Assembly Protein

163-1-2
(263 aa)

Euchromatic Histone Lysine N-Methyltransferase 2

*The length of the peptide in each clone is indicated in parentheses.
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peptide (Figure 2.2A and B, respectively). None of the other putative peptide partners interacted
with Oas1bΔTM in vitro. To determine whether these two peptides could also interact with
Oas1bt, co-immunoprecipitation experiments were performed with in vitro synthesized, Nterminal c-Myc tagged Oas1bt and each of the two partners. The ORP1L peptide did not coimmunoprecipitate with Oas1bt (Figure 2.2C), suggesting that the interaction between this
peptide and Oas1bΔTM occurs in a region located after the premature stop codon of Oas1bt and
before the transmembrane domain of Oas1b.

In contrast, the ABCF3 peptide did co-

immunoprecipitate with Oas1bt (Figure 2.2D), indicating that this peptide interacts with both
Oas1b and Oas1bt in a region upstream of the premature stop codon of Oas1bt. Also, a yeast
two-hybrid screen using Oas1a as bait identified ABCF3 to interact, suggesting that ABCF3
interacts with multiple mouse OAS proteins and possibly human OAS proteins and isoforms.
Because the peptides used in the previous experiments represented only a portion of each
of the putative interaction partners and the interactions were detected either in vitro or in yeast
cells, the results could not predict whether the whole proteins would interact with full length
Oas1b. The interaction of Oas1b and a full length partner was next tested in mammalian cells by
co-immunoprecipitation. Oas1b is one of eight duplicated Oas1 genes in mouse cells (Perelygin
et al., 2002). Due to the high degree of homology between the Oas1 proteins, it has not been
possible to make an antibody that can specifically detect individual mouse Oas1 proteins.
Therefore, a tagged Oas1b protein was transiently expressed. He MEFs were stably transfected
with both 3xFLAG-tagged full length Oas1b and V5-tagged ORP1L (He-Oas1b/Orp1L), as
described in the Materials and Methods. The in vivo interaction between Oas1b and either
ORP1L or ABCF3 was assessed by co-immunoprecipitation as described in the Materials and
Methods. Prior to lysis, cells were treated with DSP, a thiol-reversible chemical protein-
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Figure 2.2. In vitro co-immunoprecipitation of Oas1bΔTM and putative partner peptides
16-1 (Orp1L) and 42-3-5 (Abcf3). Wheat germ extract was used to in vitro transcribe and
translate Oas1bΔTM or Oas1bt and putative peptide clones in the presence of [35S]-methionine.
One of the Oas1b proteins and a candidate peptide were mixed and immunoprecipitated.
Immunoprecipitated protein complexes were resolved by SDS-PAGE and detected by
autoradiography. (A) 35S-labeled c-Myc-tagged Oas1bΔTM and HA-16-1 (Orp1L) peptides were
immunoprecipitated with anti-HA antibody. (B) 35S-labeled c-Myc-tagged Oas1bΔTM and HA42-3-5 (Abcf3) peptides were immunoprecipitated with anti-HA antibody. (C) 35S-labeled cMyc-tagged Oas1bt and HA-16-1 (Orp1L) peptides were immunoprecipitated with anti-HA
antibody. (D) 35S-labeled c-Myc-tagged Oas1bt and HA-42-3-5 (Abcf3) peptides were
immunoprecipitated with anti-HA antibody. Lys-lysates; C-Control (agarose beads alone or antiIgG antibody); α-HA-anti-HA antibody.
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rosslinker, to stabilize transient or weak interactions. Antibody to the Oas1b FLAG tag
immunoprecipitated both ORP1L and ABCF3 (Figure 2.3). The interaction of these proteins was
also analyzed in WNV-infected cells. He-Oas1b/Orp1L cells were infected with WNV Eg101 at
a MOI of 1 and harvested at 24 hr after infection. Both ORP1L and ABCF3 were
immunoprecipitated by antibody to the Oas1b FLAG tag in infected cells (Figure 2.3). In
contrast, anti-FLAG antibody did not immunoprecipitate WNV NS3 (Figure 2.3), suggesting that
Oas1b does not interact directly with WNV replication complexes and that the coimmunoprecipitation results obtained were specific.

The effect of reducing ORP1L protein levels on virus infections
The previous experiments showed that ORP1L interacts with Oas1b in vivo. It was
hypothesized that if ORP1L is an essential component of the Oas1b-mediated anti-flavivirus
mechanism, then the WNV yield, as well as viral RNA (vRNA) and protein levels would
increase when ORP1L is knocked down. ORP1L protein expression was reduced by stable
expression of an ORP1L-specific shRNA in KI MEFs. Clonal cell lines were selected as
described in the Materials and Methods. The KI shOrp1L-6 clonal cell line had the lowest
ORP1L protein levels compared to the KI shCont-7 non-specific control cell line of the 19 lines
tested (Figure 2.4A). KI shCont-7 and KI shOrp1L-6 cells were infected with WNV Eg101 at a
MOI of 1 and clarified culture fluid, total cell RNA, and cell lysates were harvested at the
indicated times after infection from duplicate wells. Virus yields were measured by plaque assay
on BHK cells and the yields produced by KI shOrp1L-6 cells at 24 to 48 hr after infection were
reduced compared to those from KI shCont-7 cells (Figure 2.4B). Intracellular viral RNA was
detected by real time qRT-PCR using WNV NS1 region-specific primers and probe. Reduced
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Figure 2.3. Mammalian cell co-immunoprecipitation of V5-tagged Orp1L and endogenous
Abcf3 with FLAG-tagged Oas1b. He-Oas1b/Orp1L MEFs that express N-terminally FLAGtagged Oas1b and C-terminally V5-tagged Orp1L were either mock-infected or infected with
WNV Eg101 (MOI of 1), treated with 0.5 mM DSP for 30 min on ice to stabilize transient or
weak interactions. The reaction was quenched with 50 mM Tris pH 7.5 for 15 min on ice, cells
were harvested at 24 hr in lysis buffer. Lysates were immunoprecipitated with either control
antibody or anti-FLAG antibody, as indicated. Western blotting was done to detect Orp1L (antiV5 antibody), Abcf3 (anti-Abcf3 antibody), NS3(anti-NS3 antibody), and Oas1b protein (antiFLAG antibody). Lys-lysates; C-Control (anti-IgG antibody-conjugated agarose); FLAG-antiFLAG antibody-conjugated agarose.
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viral RNA (vRNA) levels in KI shOrp1L-6 cells were observed from 24 to 48 hr after infection
compared to those in KI shCont-7 cells (Figure 2.4C). Western blotting of the WNV NS3 protein
showed that viral protein levels were also reduced in KI shOrp1L-6 cells compared to KI
shCont-7 at 24 to 48 hr after infection (Figure 2.4D). To confirm that the results observed were
due to the reduction of ORP1L protein and not to a decrease in cell viability, an MTT assay was
performed. Approximately 15% cell death was observed at 48 hr after Eg101 infection in both
cell lines compared to mock-infected cells (Figure 2.4E). It was noted that the efficiency of
ORP1L knockdown by shRNA decreased with time after WNV infection suggesting that the
RNAi pathway was antagonized in infected cells.
The antiviral activity of Oas1b is specific to flaviviruses. Therefore, if ORP1L is
involved in the Oas1b-mediated resistance mechanism its reduction would be unlikely to affect
an infection with a virus from another family. To test this hypothesis, wildtype B6 and KI MEFs
were infected with a member of another positive strand RNA virus family, the alpha togavirus
Sindbis virus (SinV), at an MOI of 20 and clarified culture fluid and infected cell lysates were
harvested at the indicated times after infection from replicate wells. Virus yields and intracellular
viral protein levels were similar from the two types of cells (Figure 2.5A and B). These results
confirmed the flavivirus-specificity of Oas1b-mediated resistance. The affect of ORP1L
knockdown on a SinV infection in Oas1b-expressing cells was next assessed. KI shCont-7 and
KI shOrp1L-6 cell lines were infected with SinV at an MOI of 20. SinV yields from KI
shOrp1L-6 MEFs were reduced by ~0.5-1 log compared to those from KI shCont-7 MEFs
(Figure 2.5C). A reduction was also observed in SinV capsid protein levels in KI shOrp1L-6
MEFs compared to KI shCont-7 MEFs (Figure 2.5D). A negative effect on the yield of the
negative strand RNA virus vesicular stomatitis virus (VSV) was also observed (Figure 2.5F).
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Figure 2.4. The effect of Orp1L knockdown on WNV infection in KI MEFs stably
expressing shRNAs targeting Orp1L. (A) Western blot analysis of Orp1L protein levels in KI
shCont-7 and KI shOrp1L-6 MEFs were detected using anti-Orp1L R247 antibody. KI shCont-7
and KI shOrp1L-6 MEFs were infected with WNV Eg101 at a MOI of 1. (B) Virus yields from
infected KI shCont-7 and KI shOrp1L-6 MEFs were determined by plaque assay in BHK cells.
(C) Viral RNA levels were assayed by real time qRT-PCR. (D) Viral protein (NS3) levels were
measured by Western blotting. (E) KI shCont-7 and KI shOrp1L-6 MEFs were infected with
WNV Eg101 at a MOI of 1 and analyzed for cell death using a Cell Titer 96® non-radioactive
cell proliferation assay according to manufacturers protocol.
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Figure 2.5. The effect of Orp1L knockdown on Sindbis virus and vesicular stomatitis virus
infections. (A and B) Wildtype B6 (Oas1bt-expressing) and KI (Oas1b-expressing) cells were
infected with Sindbis virus (SinV) at a MOI of 20. (A) SinV yields from B6 and KI MEFs were
measured by plaque assay on BHK cells. (B) SinV capsid protein levels in B6 and KI-infected
MEF lysates were determined by Western blotting. (C and D) KI shCont-7 and KI shOrp1L-6
cells were infected with SinV at a MOI of 20. (C) SinV yields from infected KI shCont-7 and KI
shOrp1L-7 MEFs were measured by plaque assay in BHK cells. (D) SinV capsid protein levels
from infected KI shCont-7 and KI shOrp1L-7 MEFs were determined by Western blotting. (E)
Wildtype B6 (Oas1bt-expressing) and KI (Oas1b-expressing) cells were infected with Vesicular
stomatitis virus (VSV) at a MOI of 5. VSV yields from B6 and KI MEFs were measured by
plaque assay on BHK cells. (F) VSV yields from infected KI shCont-7 and KI shOrp1L-7 MEFs
were measured by plaque assay in BHK cells.
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The results suggest that ORP1L may be a proviral host cell protein that is utilized by different
families of RNA viruses. However, knockdown of ORP1L was previously reported to enhance
the movement of late endosomes (Vihervaara et al., 2011) and this could negatively affect the
replication of viruses that enter cells by endocytosis by altering the fusion stage of viral genome
release.

The effect of reducing ABCF3 protein levels on virus infections
Since ABCF3 was also shown to interact with Oas1b in vivo, the effect of reducing
ABCF3 protein levels on WNV infection in KI cells was determined. shRNAs targeting ABCF3
or a non-specific shRNA control were transduced into KI cells and clonal cell lines were selected
as described in Materials and Methods. The KI shAbcf3-8 clonal cell line had the greatest
knockdown efficiency of ABCF3 protein as compared to the KI shCont-7 control cell lines of 21
lines tested (Figure 2.6A). KI shCont-7 and KI shAbcf3-8 MEFs were infected with WNV
Eg101 at a MOI of 1 and samples were collected for analysis at the indicated times after
infection. A slight increase in virus yields from the KI shAbcf3-8 cells were observed at 32 and
48 hr after infection compared to those from KI shCont-7 cells (Figure 2.6B). An increase in the
levels of WNV vRNA and NS3 protein was also observed compared to those in KI shCont-7
cells (Figure 2.6C and D). An MTT assay done on KI shCont-7 and KI shAbcf3-8 cells at 24 and
48 hr after infection with WNV Eg101 at a MOI of 1 detected about 15% cell death at 48 hr after
infection in both cell lines compared to mock-infected cells (Figure 2.6E). Similar to that which
was seen with infection of KI shOrp1L-6 cells, a decrease in the efficiency of ABCF3
knockdown by shRNA was also observed with time after WNV infection.
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Figure 2.6. The effect of Abcf3 knockdown on WNV infection in KI MEFs stably
expressing shRNAs targeting Abcf3. (A) Western blot analysis of Abcf3 protein levels in KI
shCont-7 and KI shAbcf3-8 MEFs. KI shCont-7 and KI shAbcf3-8 MEFs were infected with
WNV Eg101 at a MOI of 1. (B) Virus yields from infected KI shCont-7 and KI shAbcf3-8 MEFs
were determined by plaque assay in BHK cells. (C) Viral RNA levels were assayed by real time
qRT-PCR. (D) Viral protein (NS3) levels were measured by Western blotting. (E) KI shCont-7
and KI shAbcf3-8 MEFs were infected with WNV Eg101 at a MOI of 1 and analyzed for cell
death using a Cell Titer 96® non-radioactive cell proliferation assay according to manufacturers
protocol.
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Since the antiviral activity of Oas1b is specific to flaviviruses, the affect on a SinV
infection of knocking down ABCF3 was also tested. KI shCont-7 and KI shAbcf3-8 MEF
cultures were infected with SinV at an MOI of 20 and samples were collected as described above
at the indicated times after infection. SinV yields from KI shAbcf3-8 MEFs were the same as
those from KI shCont-7 MEFs (Figure 2.7A). Similarly, SinV capsid protein levels did not
change when ABCF3 proteins were knocked down (Figure 2.7B). VSV infections were also
tested and virus yield was not shown to be affected by the knockdown of ABCF3 (Figure 2.7C).
The data indicate that reduction of enhanced ABCF3 is involved in the Oas1b-mediated
flavivirus-specific antiviral mechanism.
To test whether the antiviral activity of ABCF3 requires the presence of Oas1b, ABCF3
expression was knocked down in B6 cells that express Oas1bt. shRNAs targeting either ABCF3
or a nonspecific shRNA control were transduced into B6 cells and clonal cell lines were selected
as described in the Materials and Methods. The B6 shAbcf3-8 clonal cell line had the greatest
reduction of ABCF3 protein levels compared to the B6 shCont-3 control cells of 8 clones tested
(Figure 2.8A). B6 shCont-3 and B6 shAbcf3-8 MEFs were infected with WNV Eg101 at an MOI
of 1 and samples were collected as described above at the indicated times after infection. No
effect on virus yield or vRNA or viral protein levels was detected in either type of cell (Figure
2.8B-D). These results indicate that the flavivirus-specific, antiviral activity of ABCF3 requires
the presence of Oas1b.
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Figure 2.7. The effect of Abcf3 knockdown on SinVand VSV infections. KI shCont-7 and KI
shAbcf3-8 MEFs were infected with SinV at a MOI of 20. (A) SinV yields from infected KI
shCont-7 and KI shAbcf3-8 MEFs were measured by plaque assay in BHK cells. (B) SinV
capsid protein levels from infected KI shCont-7 and KI shAbcf3-8 MEFs were determined by
Western blotting. (C) KI shCont-7 and KI shAbcf3-8 MEFs were infected with VSV at a MOI of
5. VSV yields from infected KI shCont-7 and KI shAbcf3-8 MEFs were measured by plaque
assay in BHK cells.
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Figure 2.8. The effect of Abcf3 knockdown on WNV infection in B6 MEFs stably
expressing shRNAs targeting Abcf3. (A) Western blot analysis of Abcf3 protein levels in B6
shCont-3 and B6 shAbcf3-8 MEFs. B6 shCont-3 and B6 shAbcf3-8 MEFs were infected with
WNV Eg101 at a MOI of 1. (B) Virus yields from infected B6 shCont-3 and B6 shAbcf3-8
MEFs were determined by plaque assay in BHK cells. (C) Viral RNA levels were assayed by
real time qRT-PCR. (D) Viral protein (NS3) levels were measured by Western blotting.
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DISCUSSION
The enzymatically inactive Oas1b protein mediates its anti-flaviviral effect by an as yet
unknown mechanism that is independent of the canonical RNase L pathway (Elbahesh et al.,
2011a; Perelygin et al., 2002; Scherbik et al., 2007a). Twenty-three candidate binding partners of
Oas1b were identified in a yeast two-hybrid screen of a mouse brain library and 8 of these were
confirmed by co-transformation of yeast. However, only two of the candidate peptides, ORP1L
and ABCF3, were identified as interaction partners of Oas1b in vitro. Full length proteins of
these two partners were also shown to interact with Oas1b in mammalian cells. The lack of an in
vitro Oas1b interaction for 6 of the 8 putative partners could be due to a false positive interaction
in yeast or to misfolding or the lack of modification of the in vitro translated peptides. The
interaction of each of these full length proteins with Oas1b still needs to be tested. The coimmunoprecipitation results suggest that Oas1b, ORP1L and ABCF3 form a complex in
mammalian cells. Also, ORP1L and ABCF3 interact with different regions of the Oas1b protein,
further supporting the idea that these proteins do not compete with each other for Oas1b binding.
ORP1L belongs to the oxysterol-binding protein (OSBP)-related protein family that is
involved in processes such as cholesterol maintenance, sterol sensing, lipid transport, and cell
signaling events (Lehto et al., 2001; Lehto and Olkkonen, 2003; Olkkonen et al., 2006; Xu et al.,
2001; Yan et al., 2007b). ORP1L is one of two variants of ORP1, the other of which is ORP1S
(Johansson et al., 2003). ORP1L contains an N-terminal extension of ankyrin repeats (a unique
feature among the OSBP-related proteins) and a pleckstrin homology domain in addition to the
OSBP domain, whereas ORP1S contains only the OSBP domain common to all OSBP-related
proteins (Johansson et al., 2003). These two variants differ in their tissue expression, intracellular
localization and function. ORP1S is predominantly expressed in skeletal muscle and heart, while
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ORP1L is expressed in macrophages, brain and lungs (Johansson et al., 2003). ORP1S is a
cytosolic protein while ORP1L localizes to late endosomes (LEs) and colocalizes with LE
proteins such as Rab7, Rab9, Rab7-interacting lysosomal protein (RILP), and lysosomal
associated membrane protein 1 (LAMP1) (Johansson et al., 2003; Johansson et al., 2005;
Johansson et al., 2007). ORP1L was recently shown to be involved in LE movement along
microtubules (Johansson et al., 2005; Johansson et al., 2007; Rocha et al., 2009; Vihervaara et
al., 2011). Rab7 recruits RILP and ORP1L to form a complex. RILP, present in this complex,
can interact with the p150Glued subunit of dynactin to recruit the dynein motor complex
(Johansson et al., 2007). The dynein motor complex then facilitates minus-end-directed
translocation of LEs towards the microtubule organizing center of the cell (Johansson et al.,
2007; Rocha et al., 2009). The function of ORP1L in this complex is to sense the cholesterol
content of LEs. In low cholesterol conditions, ORP1L is in an open conformation, exposing a
motif containing two phenylalanines in an acidic tract (FFAT) that can interact with the vesicleassociated membrane protein (VAMP)-associated protein A (VAP-A) which removes the
p150Glued subunit from the motor complex inhibiting the movement of LEs on microtubules. This
results in a scattered distribution of LEs within the cell (Rocha et al., 2009). In contrast, when
cholesterol levels are high the ORP1L is in a closed conformation in which the FFAT motif is
not available for interaction with VAP-A. This facilitates minus-end directed transport of LEs
(Rocha et al., 2009). A recent study on the effects of ORP1L on LE motility showed that
knockdown of ORP1L expression results in an increase in LE motility, whereas ORP1L
overexpression results in the clustering of LEs to the perinuclear region of the cell (Rocha et al.,
2009; Vihervaara et al., 2011).
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Flaviviruses attach to an unknown cell surface receptor(s) located in a cholesterol raft and then
enter cells by endocytosis in clatherin-coated pits (Lindenbach, 2007; Medigeshi et al., 2008).
Acidification of early endosomes leads to a conformational change in the viral envelope (E)
protein but LE compartment-specific anionic lipids are required to trigger E fusion loop insertion
into the membrane initiating fusion of the two membranes (Zaitseva et al., 2010). ORP1L
sensing cholesterol in the lipid rafts of virion-containing LEs would remain in a closed
conformation facilitating the movement of virion-containing LEs on microtubules (Olkkonen and
Hynynen, 2009; Xu et al., 2001). For both WNV, SinV and VSV infections, late endosomes are
the site of virion fusion during entry (Chu and Ng, 2004; Lu et al., 1999; Superti et al., 1987) and
the negative effect of knocking down Orp1L each of these types of infection could be due to a
non-specific effect of increased late endosome motility rather than to a specific effect on the
flavivirus resistance mechanism. Alternative experimental strategies are therefore required to
study the involvement of ORP1L in the Oas1b-mediated flavivirus resistance mechanism. The
interaction of Oas1b with ORP1L may stop the movement of virus-containing LEs on
microtubules and bring them close to the ER.
The ABC superfamily of ATP-binding proteins is one of the largest protein families
known with highly conserved ABC proteins found in archaea, prokaryotes, and eukaryotes
(Hollenstein et al., 2007; Linton and Higgins, 2007; Locher, 2009; Schriml and Dean, 2000;
Sturm et al., 2009). ABC proteins are canonical transporters of numerous substrates and are
typically exporters; however, prokaryotic ABC proteins can also function as importers
(Hollenstein et al., 2007; Locher, 2009). Seven subfamilies of ABC proteins (a-g) have been
identified in humans. Because the ABCE and ABCF subfamilies are non-canonical ABC
transporters that lack transmembrane domains (Kerr, 2004; Sturm et al., 2009), it has been
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suggested that they do not function as typical ABC transporters but instead are involved in other
processes such as regulating translation initiation and/or elongation, ribosome assembly, and
RNase L activity (Chen et al., 2006; Kerr, 2004; Martinand et al., 1999; Paytubi et al., 2008;
Sturm et al., 2009; Tyzack et al., 2000). Although nothing is yet known about ABCF3 protein
function in mammalian cells, recent reports have suggested that some proteins of both the ABCE
and ABCF families may share host cell binding partners (Chen et al., 2006; Paytubi et al., 2008;
Tyzack et al., 2000). Both ABCE and ABCF proteins have been shown to regulate protein
synthesis by binding translation initiation factors. Data from the present study showed that
reducing ABCF3 protein levels had the greatest effect on viral protein levels. The
transmembrane tail of Oas1b specifically localizes it to the ER membrane, the site of flavivirus
translation and replication and the recruitment of ABCF3 is required for its antiviral affect. The
mechanism by which ABCF3 specifically decreases flavivirus replication is not yet known, but
downregulation of WNV protein synthesis would lead to downregulation of viral RNA synthesis
and progeny virus production. It is possible that the antiviral activity of ABCF3 depends on its
specific localization to the ER membrane as mediated by binding to Oas1b, which is unique
among OAS proteins in having a transmembrane domain.
The ABCE1 protein has also been reported to interact with partners that are not involved
in translation. ABCE1 was initially reported to be a protein involved in inhibiting RNase L
activation by binding 2-5As but it was subsequently shown to directly bind to RNase L (Bisbal et
al., 1995). An equimolar ratio of ABCE1 and RNase L was shown to be required for inhibition
(Bisbal et al., 1995). However, a previous studies in our lab showed that while RNase L activity
partially reduces WNV yield, the effect was similar in cells expressing either full length or
truncated Oas1b and the canonical RNase L pathway was shown not to be involved in the Oas1b-
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mediated resistance to flavivirus-induced disease (Elbahesh et al., 2011a; Scherbik et al., 2006).
ABCE1 was also reported to bind to TULA, a protein containing both ubiquitin binding domains
and SH3 domains, leading to the inhibition of the production of HIV-1 viral particles (Agrawal et
al., 2008; Carpino et al., 2004; Feshchenko et al., 2004; Kowanetz et al., 2004; Smirnova et al.,
2008; Wattenhofer et al., 2001). ABCF3 was also found to interact with Oas1a and Oas1bt
(Figure 2.2D). What functions it plays when interacting with these proteins are also not currently
known. ABCF3 may interact with different partners and have different functions depending on
the complex that it is in.

MATERIALS AND METHODS
Cell Lines
C3H/He (He), C3H/RV, C57BL/6 (B6) and C57BL/6-Oas1bKI (KI) SV40-transformed
mouse embryofibroblast (MEF) lines, as well as BHK-21 W12 cells, were maintained in minimal
essential medium (MEM) supplemented with 5% heat-inactivated fetal bovine serum (FBS),
glutamine, and 10 µg/mL gentamicin at 37ºC in 5% CO2.
He MEFs were transiently transfected with a p3xFLAG-Oas1b plasmid using
Lipofectamine 2000, according to the manufacturer’s protocol (Invitrogen). Transfected cells
were selected using 250 µg/mL G418 (Sigma) to create a heterogeneous population of cells
stably expressing FLAG-Oas1b, referred to here as He-Oas1b cells. Stable integrants from
individual foci were selected from cloning rings and subsequently expanded. Homogeneous
clonal cell lines were generated by plating cells at a limiting dilution, harvesting colonies with
cloning rings and expanding the individual colony cell populations. Multiple clones were
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selected and analyzed for FLAG-Oas1b protein expression. Clone #12 (He-Oas1b-12) had the
highest Oas1b expression level and was used for experiments.
He-Oas1b-12

cells

were

transfected

with

pEF6-V5/HIS-TOPO-Orp1L

using

Lipofectamine 2000, according to manufacturer’s protocol (Invitrogen). These cells were then
selected using 5 µg/mL Blasticidin S hydrochloride (Sigma), as well as G418, to obtain a cell
population that stably expressed both FLAG-Oas1b and V5-Orp1L, called He-Oas1b/Orp1L.
The KI (Oas1b-expressing) and B6 (Oas1bt-expressing) MEF lines were previously
described (Scherbik et al., 2007a) and used for RNAi studies. KI cells were transduced with
lentiviral-packaged shRNA targeting either mouse Orp1L (sc-62716-V), mouse Abcf3 (sc140761-V), or a non-specific shRNA control (sc-108060-V) (Santa Cruz Biotechnology)
according to the manufacturer’s protocol. Heterogeneous cell populations stably expressing the
targeted shRNAs were selected using 5 µg/mL puromycin dihydrocholoride (Santa Cruz
Biotechnology). Clonal lines were selected by plating cells at a limiting dilution, harvesting
colonies with cloning rings and expanding the individual colony cell populations. The
knockdown efficiency of each clone was determined using Western blotting to detect protein and
real time qRT-PCR to detect mRNA. The KI shControl clone #7 (KI shCont-7) cells had
comparable levels of Orp1L and Abcf3 to the wildtype KI cells and were used in the
experiments. The same protocol was used to generate B6 shControl clone #3 (B6 shCont-3) cells.

cDNA Constructs
The full length Oas1b cDNA was amplified from C3H/RV RNA by RT-PCR, cloned into
a pScreen vector (Invitrogen) and then subcloned into the pGBKT7 vector (Clontech) using
Nco1 and BamH1 restriction enzyme sites. Similarly, full length Oas1b was amplified from

49
C3H/RV RNA, cloned into a TOPO vector (Invitrogen) and then subcloned into the pEBG
vector (a gift from Dr. Hobman, University of Alberta) that fuses an N-terminal GST tag onto the
expressed protein (GST-Oas1b). Also, truncated Oas1b (Oas1bt) was amplified from C3H/He
RNA, cloned into a TOPO vector and then subcloned into the pEBG vector (GST-Oas1bt). A
construct expressing an Oas1b protein without the predicted C-terminal transmembrane domain
(Oas1bΔTM) was generated by PCR amplification of the cDNA sequence corresponding to
amino

acids

1-353

of

the

Oas1b

CATATGATGGAGCAGGATCTG-3′

protein
and

using
the

the

forward

reverse

primer

primer

5′5′-

GAATTCCTAATACTTCATTGG-3′ followed by cloning into a TOPO vector and then
subcloning into pGBKT7 (Clontech) using Nde1 and EcoR1 restriction enzyme sites. For
mammalian cell expression, Oas1b cDNA was subcloned from a pNTAP-Oas1b plasmid into the
p3xFLAG-CMV-10 vector (Sigma) using EcoR1 and Xba1 restriction sites (p3xFLAG-Oas1b).
Full length Orp1L cDNA was reverse transcribed from He cell RNA using a Thermoscript RTPCR

kit

(Invitrogen)

with

the

Orp1LF

forward

primer

5′-

GCCATGAACACAGAAGCAGAACAGCAGCTTCTC-3′ and the Orp1LR reverse primer 5′ATAAATATCAGGCAAATTGAAGTAGTTTCTGTC-3′ then PCR amplified using the
Platinum Taq DNA Polymerase High Fidelity kit (Invitrogen) using the Orp1LF and Orp1LR
primers and subsequently cloned into the pEF6-V5/HIS-TOPO vector (Invitrogen), creating the
pEF6-V5/HIS-TOPO-Orp1L (pEF6-Orp1L) construct for mammalian cell expression. All
constructs were sequenced to verify that they contained the correct sequence.
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Transient Transfection
BHK cells were seeded to approximately 80% confluency and transiently transfected
with cDNA expressing GST-Oas1b, GST-Oas1bt, or GST tag alone using Lipofectamine 2000
(Invitrogen) according to manufacturer’s protocol.

Viruses
A stock of lineage 1 WNV strain Eg101 was prepared by infecting a monolayer of BHK
cells at a multiplicity of infection (MOI) of 0.1 and harvesting culture fluid at 32 hr after
infection. Clarified culture fluid (5x107 PFU/ml) was aliquoted and stored at -80ºC. A stock of
Sindbis virus strain SAAR339 (7x109 PFU/ml) was prepared as a 10% (wt/vol) newborn mouse
brain homogenate.

Plaque Assay
Infectivity titers were determined by infecting monolayers of BHK cells in duplicate well
of a six-well plate with serial 10-fold dilutions of clarified culture fluid. After adsorption for 1 hr
at RT, the virus inoculum was removed and the wells were overlaid with 1% SeaKem ME
agarose (Bio-Whittaker Molecular Applications, Rockland, Maine), mixed 1:1 with 2x MEM
containing 5% FBS, and incubated for 72 hr at 37ºC in 5% CO2. Plaque assays were performed
in BHK cells with the same protocol for SinV but the plates were incubated for 48 hr. After
removal of the agarose plugs, cells were stained with 0.05% crystal violet in 10% ethanol.
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Yeast Two-Hybrid Analysis
Yeast two-hybrid analyses were performed according to manufacturer’s protocol
(Clontech). Oas1bΔTM was cloned into the pGBKT7 vector (Clontech) which was transformed
into AH109 yeast cells (bait). The Oas1bΔTM-transformed AH109 cells were mated with pretransformed Y187 yeast cells (Mouse Brain cDNA library (prey)) (Clontech). Yeast two-hybrid
analysis yielded a mating efficiency of ~1.58% and approximately 2.1x106 clones were screened.
Diploid yeast cells were plated onto triple drop-out (TDO; SD/-His/-Leu/-Trp) agarose selection
plates and incubated at 30ºC. Colonies were selected from TDO plates and re-streaked onto
quadruple drop-out (QDO; SD/-Ade/-His/-Leu/-Trp) agarose plates for a more stringent
secondary selection. Colonies growing on QDO selection plates were then further tested for
Gal4-mediated MEL1 activation, one of the Gal4-responsive reporter genes of the yeast twohybrid system. Alpha-glactosidase production from MEL1 turns X-α-Gal into a blue product and
therefore suggests a positive interaction.

Yeast Co-transformation
A yeast co-transformation analysis was performed according to the manufacturer’s
protocol (Clontech). Oas1bΔTM-transformed AH109 yeast cells were mated with individual
putative partner positive clones transformed into Y187 yeast cells and diploid cells were plated
onto double drop-out (DDO; SD/-Leu/-Trp) selection plates to confirm co-transformation, as
well as onto QDO plates to confirm a positive interaction identified in the yeast two-hybrid
screen.
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In Vitro Transcription and Translation
Putative positive clones and bait constructs were in vitro transcribed and translated in the
presence of 20 µCi 35S-labeled methionine (EasyTagTM Met L-[35S] Perkin Elmer), according to
manufacturer’s protocol (Promega).

In Vitro Co-immunoprecipitation
Two 35S-methionine-labeled, in vitro translated peptides were incubated together for 1 hr
at RT. The reaction was then divided into two and incubated with either a control (agarose alone
or anti-IgG antibody) or with anti-HA antibody (Roche) for 1 hr with rotation at 4ºC, after which
Protein G agarose (Roche) was added and rotation was continued at 4ºC overnight. The beads
were then washed 3 times in lysis buffer (1% Triton X-100, 0.1% SDS, 150 mM NaCl, 50 mM
Tris HCl pH 7.4, and fresh protease inhibitor). The beads were centrifuged and 30 µl of 2x
sample buffer (20% SDS, 25% glycerol, 0.5 M Tris HCl pH 6.8, and 0.5% bromophenol blue)
was added and the samples were boiled at 95ºC to denature the protein complexes.
Immunoprecipated proteins were separated by SDS-PAGE in 10% polyacrylamide gels. Gels
were washed 3 times in fixing solution (10% acetic acid and 30% methanol) to remove free
radiolabeled methionine and then incubated for 30 min at RT in Autofluor (National
Diagnostics), incubated for 5 min at RT in an anti-cracking buffer (7% acetic acid, 7% methanol,
and 1% glycerol), and then dried onto 3 mm chromatography paper (Whatman) using a Model
543 Gel Dryer (BIO-RAD). Dried gels were exposed to HyBlot CL® autoradiography film
(Denville) at -80ºC and bands were detected by autoradiography.
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Mammalian Cell Co-immunoprecipitation
Approximately 2x107 cells were washed twice with 1xPBS and then treated with 0.5 mM
dithiobis[succinimidyl propionate] (DSP) for 30 min at RT to crosslink cellular proteins. The
reaction was quenched with 50 mM Tris pH 7.5 for 15 min on ice. The cells were rinsed in
1xPBS, incubated on ice for 30 min after the addition of 1.5 ml lysis buffer and then passed
through a 21 gauge syringe. Cell lysates were clarified by centrifugation at 2,000 x g at 4ºC for 5
min. The supernatant was divided in two and incubated with either anti-IgG antibody-conjugated
Protein G agarose beads (Sigma) or with anti-FLAG antibody-conjugated Protein G agarose
beads (Sigma) at 4ºC overnight. The beads were washed 3 times in lysis buffer to remove
unbound proteins, centrifuged and 30 µl of 2x sample buffer was added. Sample buffer contains
β-mercaptoethanol which reverses the chemically crosslinked proteins from the DSP treatment.
The beads were boiled at 95ºC for 5 min to denature the protein complexes and the samples were
sonicated. Immunoprecipitated proteins were separated by SDS-PAGE and transferred to a
nitrocellulose membrane for 1 hr at 100V. After transfer, membranes were blocked for 1 hr at RT
in 5% non-fat dry milk (NFDM), incubated with a primary antibody diluted in 5% NFDM
overnight at 4ºC, washed 3 times for 10 min in 1xTBS+Tween 20 and then incubated with a
secondary antibody diluted in 5% NFDM for 1 hr at RT. Membranes were washed twice in
1xTBS+Tween 20, once in 1xTBS for 10 min at RT and then incubated in SuperSignal West
Pico Chemiluminescent Substrate (Thermo Scientific) for 5 min at RT and bands were detected
by autoradiography.
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Antibodies
The primary antibodies used in immunoblotting experiments were: mouse anti-c-Myc and
mouse anti-HA (Roche), mouse anti-FLAG, rabbit anti-FLAG, and rabbit Abcf3 (Sigma), goat
anti-V5 (Bethyl Laboratories), goat anti-NS3 (R&D Systems), and rabbit anti-Orp1L R247 (a
kind gift from Dr. Olkkonen, Helsinki, Finland). The primary antibodies used in confocal
microscopy studies were: mouse anti-GST, rabbit anti-GST (Cell Signaling), rabbit anti-Calnexin
(Sigma), mouse anti-CoxIV (Invitrogen), and mouse anti-dsRNA (Hungary). Secondary
antibodies used for immunoblotting experiments included anti-Rabbit-HRP, anti-Mouse-HRP
(Cell Signaling), and anti-Goat-HRP (SCBT). Secondary antibodies used for confocal
microscopy studies included donkey anti-Mouse Alexa Fluor 594, donkey anti-Mouse Alexa
Fluor 488, donkey anti-Rabbit Alexa Fluor 488, and donkey anti-Rabbit Alexa Fluor 594
(Invitrogen).

Confocal Microscopy
BHK cells were seeded onto 3 mm coverslips (Fisher Scientific) in 24-well plates and 20
hr later infected with WNV Eg101 at an MOI of 1, fixed with 4% paraformaldehyde in
phosphate buffered saline (PBS) for 10 min at RT, permeablized with 0.1% Triton X-100 in PBS
for 10 min, and rinsed three times with PBS, and incubated overnight at 4ºC in blocking buffer
(5% horse serum in PBS). Primary antibodies were diluted in blocking buffer and incubated with
cells for 1 hr at RT. The cells were washed three times for 10 min in PBS and then incubated
with the secondary antibodies and 0.5 µg/ml Hoechst 33258 dye (Invitrogen) for 1 hr at RT.
Coverslips were mounted using ProLong Gold Antifade reagent (Invitrogen) and images were
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taken with a LSM 510 confocal microscope (Zeiss, Oberkochen, Germany) using a 63x waterimmersion objective. Images were analyzed using Zeiss LSM Image Browser software.

Real time qRT-PCR
Total cellular RNA was isolated from B6 and KI cells with TriReagent (Molecular
Research Center). Cellular and viral RNA were quantified using a TaqMan One-Step RT-PCR
Master Mix Reagents Kit (Applied Biosystems) according to manufacturer’s protocol. Mouse
Orp1L (Mm_00498552_m1) and mouse Abcf3 (Mm_00658695_m1) cellular RNA levels were
measured using predesigned primer and probe sets (Applied Biosystems). WNV Eg101 NS1
RNA was measured using a previously described primer and probe set (Scherbik et al., 2006).
Mouse GAPDH was used as an internal loading control.

MTT Assay
Cells were plated to ~100% confluency in 96-well plates and infected with WNV Eg101
at a MOI of 1. Cell viability was determined at 24 hr and 48 hr after infection using a CellTiter
96® non-radioactive cell proliferation assay done according to manufacturer’s protocol
(Promega).
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CHAPTER 3

Specific Aim 2: To analyze the formation of virus-induced stress granules during infection
of BHK cells with a WNV lineage 1/2-based infectious clone.

INTRODUCTION
West Nile virus is maintained in nature in a mosquito-bird transmission cycle and has
recently become endemic in the United States. Humans and horses are occasionally infected but
are dead end hosts (Brinton, 2002; Lindenbach, 2007). Infections in humans are usually
asymptomatic but some individuals develop fever and/or flu-like symptoms and a few of these
progress to central nervous system disease (Brinton, 2002; Lindenbach, 2007). WNV belongs to
the family Flaviviridae, genus Flavivirus, which includes other mosquito-borne human
pathogens such as dengue virus, yellow fever virus (YFV) and Japanese encephalitis virus. The
WNV genome is a positive-sense, single-stranded RNA that contains a 5′ cap but no 3′ poly(A)
tail (Lindenbach, 2007). It is approximately 11,000 nts in length and encodes a single
polyprotein that is co- and post-translationally processed by both host and viral proteases into
three structural [capsid (C), membrane (M) and envelope (E)] and seven non-structural (NS1,
NS2a, NS2b, NS3, NS4a, NS4b and NS5) proteins (Lindenbach, 2007). Most of the more than
70 strains of WNV are classified in either lineage 1 or 2 (Bakonyi et al., 2006; Lanciotti et al.,
2002; Prilipov et al., 2002). Lineage 1 WNV strains are endemic in northern Africa, Europe, the
Middle East, parts of Asia and the Americas, while lineage 2 WNV strains are typically found in
sub-Saharan Africa (Bakonyi et al., 2006; Lanciotti et al., 2002; Prilipov et al., 2002).
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In response to several types of cellular stress, eukaryotic translation initiation factor 2
alpha (eIF2α) Ser51 is phosphorylated by one of four kinases: protein kinase R (PKR), activated
by dsRNA (viral infection); heme-regulated initiation factor 2α (HRI), activated by oxidative
stress; PKR-like endoplasmic reticulum kinase (PERK), activated by unfolded proteins in the
endoplasmic reticulum (ER); and general control nondepressible 2 (GCN2), activated by amino
acid starvation (Anderson and Kedersha, 2008). Phosphorylation of eIF2α reduces the amount of
available eIF2-GTP-tRNA complexes and thus inhibits translation initiation resulting in
polysome disassembly through ribosome runoff. RNA-binding proteins such as TIA-1, TIAR,
and G3BP can then bind to the 5′ end of the mRNA with a stalled initiation complex and
aggregate with other mRNA-bound proteins forming microscopically visible stress granules
(SGs) (Anderson and Kedersha, 2002a, 2008). SGs recruit many additional proteins including
RNA-stabilizing proteins (Anderson and Kedersha, 2008; Brennan and Steitz, 2001). Although
cap-dependent translation is suppressed in stressed cells, translation from internal ribosome entry
site (IRES) elements and alternative ORFs, such as those in the mRNAs of heat shock proteins,
chaperones, and some transcription factors (i.e. ATF4), still occurs (Vattem and Wek, 2004). If a
cell survives the stress, SGs dissociate and the mRNAs resume translation (Brennan and Steitz,
2001). However, if a cell is unable to recover and enters apoptosis, stalled mRNAs in SGs are
transported to and degraded by processing bodies (PBs) (Sheth and Parker, 2003; Teixeira et al.,
2005). Some virus infections have been shown to suppress SG formation (Dougherty et al., 2011;
McInerney et al., 2005; White et al., 2007). Lineage 1 WNV Eg101 infections in BHK cells were
previously reported not to induce SGs but to inhibit SG induction by arsenite treatment (Emara
and Brinton, 2007). A subsequent study showed that infections with the lineage 2/1 infectious
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chimeric W956IC virus activated PKR while WNV Eg101 infections did not (Elbahesh et al.,
2011b).
In the present study, SG induction in BHK cells by infections with additional natural
lineage 1 or lineage 2 WNV strains and W956IC was compared. None of the natural lineage 1 or
lineage 2 WNV strains tested induced SGs by 24 hr after infection while W956IC virus
infections efficiently induced SGs starting at 12 hr after infection. All SG-positive, WNVinfected cells had elevated levels of phosphorylated eIF2α. PKR was identified as the kinase
phosphorylating eIF2α in WNV-infected cells. Mapping experiments done with a set of WNV
chimeric viruses suggested that interactions between viral nonstructural proteins and/or between
viral nonstructural proteins and cell proteins are altered in W956IC-infected cells. Increased
levels of SG-positive, chimeric virus-infected cells correlated with higher levels of early viral
RNA synthesis and the presence of viral dsRNA that was not protected by intracellular
membranes.

RESULTS
Efficiency of SG formation induced by different strains of WNV
It was previously reported that lineage 2-based W956IC virus infections induced PKR
phosphorylation while lineage 1 WNV Eg101 infections did not (Elbahesh et al., 2011b). WNV
Eg101 infections were previously reported not to induce SGs (Emara and Brinton, 2007). To
determine whether different strains of WNV varied in the efficiency with which they induced
SGs, BHK cells were infected with WNV lineage 1 strains, Eg101, NY99 or Tx113; with WNV
lineage 2 strains, B956, Mg78, or SPU; or with a lineage 1/2-based chimeric WNV infectious
clone, W956IC virus. Cells were fixed at 36 hr after infection and analyzed by confocal
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microscopy. Less than 3% of the infected cells were SG-positive by 36 hr after infection with
each of the lineage 1 and 2 WNV strains tested (Figure 3.1A), confirming our previous results
(Emara and Brinton, 2007). In contrast, W956IC infections induced SGs in ~30% of the infected
BHK cells by 36 hr after infection (Figure 3.1A and C).
The time course of SG formation in Eg101- and W956IC-infected cells was next
analyzed. BHK cells were infected with either WNV Eg101 or W956IC (MOI of 1) and then
fixed and analyzed for SGs at various times after infection. Less than 0.5% of the mock-infected
cells contained SGs at either 24 hr or 36 hr after infection (Figure 3.1B and C). No SG-positive
WNV Eg101-infected cells were detected at either 6 hr or 12 hr after infection, whereas SGpositive W956IC-infected cells were observed by 12 hr. By 24 hr (less than 1%) and by 36 hr
(less than 3%) of Eg101-infected cells contained SGs (Figure 3.1B and C). In contrast, ~20% of
the W956IC-infected cells were SG-positive at 24 hr after infection and ~30% were SG-positive
by 36 hr (Figure 3.1B and C). Differential efficiency of SG induction by Eg101 and W956IC
virus infections was also observed in C3H/He MEFs, C57BL/6 MEFs, and HEK 293T cells (data
not shown). Although the number of SG-positive infected cells and the time at which they
initially appeared differed among the cell lines tested, W956IC infections consistently induced
SGs at earlier times after infection as well as higher levels of SG-positive, infected cells
compared to Eg101 infections.
During stress, stalled pre-mRNA complexes are held in SGs and when the fate of the cell
is decided, either mRNA translation is reinitiated or the mRNAs are transferred to PBs for
degradation (Anderson and Kedersha, 2008; Beckham and Parker, 2008; Sheth and Parker,
2003). Alterations of PB number occurs in response to various stress stimuli and our lab
previously reported that the number of PBs in WNV Eg101 and dengue 2 virus infected BHK
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Figure 3.1. Stress granule formation induced by different strains of WNV. (A) BHK cells
were infected with the indicated lineage 1 or lineage 2 WNV strain at a MOI of 1, fixed at 36 hr
after infection and analyzed by confocal microscopy. Anti-G3BP antibody (green) was used to
detect SGs, anti-dsRNA antibody (red) to detect WNV-infected cells and Hoechst dye (blue) to
detect nuclei. Merged images are shown. (B) BHK cells were infected with either Eg101 (lineage
1) or W956IC (lineage 2-based infectious clone) at a MOI of 1 and analyzed for SG formation at
the indicated times after infection. Antibody staining was the same as in panel A. Cells were
collected at the indicated times after infection. Merged images are shown. (C) SG-positive
infected cells were counted to determine the percentage of Eg101- and W956IC-infected cells
containing SGs. * - represents significance compared to mock-infected cells at a 95% confidence
interval (p < 0.05). ** - represents significance compared to Eg101-infected cells at a 95%
confidence interval (p < 0.05). (D) BHK cells were infected with either Eg101 or W956IC at a
MOI of 1 and analyzed for PB formation in infected cells. Anti-Dcp1a antibody (green) was used
as a marker for PBs, anti-dsRNA antibody (red) was used to detect virus-infected cells, and
Hoechst dye (blue) was used to detect nuclei. Merged images are shown. (E) PBs were counted
to determine the average number per infected cell. * - represents significance compared to mockinfected cells at a 95% confidence interval (p < 0.05). Error bars indicate standard deviation of
the mean.
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cells was reduced by 24 hr after infection (Emara and Brinton, 2007; Teixeira et al., 2005). To
determine the effect of a W956IC virus infection on PBs, W956IC-infected BHK cells were
fixed at 36 hr after infection and analyzed by confocal microscopy. Mock-infected cells
contained an average of ~70.93 PBs/cell, whereas Eg101-infected cells had ~47.5 PBs/cell and
W956IC-infected cells had ~39.03 PBs/cell (Figure 3.1E). Both Eg101 and W956IC infections
reduced PB numbers in infected cells with a slightly greater reduction seen in the W956ICinfected cells. PB numbers were also reduced in BHK cells infected with the NY99, Tx113,
B956, Mg78, and SPU strains of WNV compared to mock infected cells (data not shown).

SG formation in WNV-infected cells is PKR-dependent
The phosphorylation of eIF2α which leads to SG formation in mammals is mediated by
four kinases, PKR, PERK, GCN2 and HRI (Anderson and Kedersha, 2008). To determine which
of these four eIF2α kinases mediates SG induction in WNV-infected cells, the eIF2α kinase
knockout MEF cell lines PKR-/-, PERK-/-, GCN2-/-, and HRI-/- (Han et al., 2001; Harding et al.,
2000; Yang et al., 1995) were mock-infected or infected with WNV Eg101 or W956IC at a MOI
of 1 and then fixed at 24 hr after infection and analyzed by confocal microscopy. C57BL/6 (B6)
and PERK+/+ (a second C57BL/6 cell line) MEFs that express all four of the eIF2α kinases were
used as controls (Harding et al., 2001). SGs were detected in both Eg101- and W956IC-infected
control, PERK-/-, GCN2-/- and HRI-/- MEFs (Figure 3.2A). Quantification of the number of SGpositive, infected cells indicated that the control, PERK-/-, GCN2-/-, and HRI-/- MEF cultures each
contained 8-12% SG-positive Eg101-infected cells or 15-20% SG-positive W956IC-infected
cells at 24 hr (Figure 3.2B). However, no SGs were observed in PKR-/- cells infected with either
virus (Figure 3.2A and B), indicating that SG induction in WNV-infected cells is PKR-
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Figure 3.2. Stress granule formation induced by WNV infection is PKR-dependent. (A)
Control MEFs (C57Bl/6 and PERK+/+) and eIF2α kinase knockout MEFs (PKR-/-, PERK-/-,
GCN2-/-, and HRI-/-) were infected with WNV Eg101 or W956IC at a MOI of 1, fixed at 24 hr
after infection and analyzed by confocal microscopy. SGs were detected with anti-G3BP
antibody (green), WNV-infected cells with anti-dsRNA antibody (red), and nuclei with Hoechst
dye (blue). Arrows denote SG-positive cells. Merged images are shown. (B) The total number of
cells and the number of SG-positive, infected cells were counted and the percentage of infected
cells containing SGs was determined as described in the Materials and Methods. * - represents
significance compared to PERK+/+ control cells for the indicated infection at a 95% confidence
interval (p < 0.05). (C) During the course of infection, BHK cells were treated with different
concentrations of 2-AP or DMSO (vehicle control), infected with W956IC at a MOI of 1, fixed
at 24 hr after infection and analyzed by confocal microscopy to observe SG formation in infected
cells. The percent of SG-positive, infected cells was calculated. (D) An MTT assay measuring
cell viability during treatment of BHK cells infected with W956IC and treated with different
concentrations of 2-AP or DMSO was performed as described in the Materials and Methods.
Error bars indicate standard deviation of the mean.
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dependent. Unlike BHK cells, these MEF cell lines are interferon (IFN)-competent and it was
previously reported that IFN production during WNV Eg101 infections leads to elevated levels
of PKR and phosphorylated PKR in IFN-competent cells as compared to IFN-/- cells (Elbahesh et
al., 2011b), possibly leading to the slight induction of SGs in Eg101-infected MEF cell cultures;
however, W956IC-infected MEFs still induced higher levels of SG-positive, infected cells
compared to Eg101-infected cells.
As an alternative means of showing that PKR is the kinase responsible for the formation
of SGs in WNV-infected cells, BHK cells were incubated with 2-aminopurine (2-AP), a purine
analog that is a potent PKR inhibitor (Hu and Conway, 1993; Lindquist et al., 2011b). BHK cells
were infected with W956IC virus (MOI of 1) for an hr and then incubated in media containing 2AP or DMSO (solvent control) for 24 hr. Approximately 20% of the W956IC-infected cells were
SG-positive in untreated, DMSO-treated and 0.2 mM 2-AP-treated cultures (Figure 3.2C). Only
10% of W956IC-infected cells were SG-positive in the 1 mM 2-AP-treated cultures and 3% were
SG-positive in 5 mM 2-AP-treated cultures (Figure 3.2C). An MTT assay showed a <4%
decrease in cell viability after of 0.2 mM 2-AP treatment, <6% decrease after 1 mM 2-AP
treatment, and ~25% decrease after 5 mM 2-AP treatment of W956IC-infected cells (Figure
3.2D). The results suggest that the dose-dependent decrease in SG formation observed with 2-AP
treatment was not due to a decrease in cell viability and further confirm that PKR is the kinase
responsible for SG formation during infection.
To determine whether PKR plays an antiviral role during WNV infections, wildtype
C57BL/6 and PKR-/- MEFs were infected with Eg101 or W956IC at a MOI of 1. Clarified
culture fluids and cell lysates were collected for growth curve and Western blot analyses. These
results showed that Eg101 infections, which slightly induce SGs in MEFs, were only slightly
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Figure 3.3. WNV Eg101 and W956IC infections replicate to higher levels in PKR-/- MEFs.
(A) Wildtype C57BL/6 and PKR-/- MEFs were infected with WNV Eg101 and W956IC at a MOI
of 1. Virus yields were measured by plaque assay at the indicated times after infection. (B)
Western blot analysis of C57BL/6 and PKR-/- MEFs infected with WNV Eg101 or W956IC at a
MOI of 1. Lysates were collected in RIPA buffer at the indicated times after infection and
analyzed using antibodies to viral NS3, PKR, and actin.
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increased in both the viral titers and viral NS3 protein in PKR-/- MEFs as compared to control
cells, whereas W956IC infections that significantly induce SGs in MEFs showed dramatic
increases in both viral titers and viral NS3 protein in PKR-/- MEFs (Figure 3.3A and B). These
results suggest that PKR activation leading to SG formation during WNV infections is antiviral
and suggests that avoiding PKR activation during WNV infection is advantageous to viral
synthesis.

W956IC infections induce higher levels of phosphorylated PKR and phosphorylated eIF2α
in BHK cells at early times after infection
Since activation of the Type I interferon signaling pathway has been reported to result in
PKR activation (Su et al., 2006), BHK cells that are not responsive to Type I interferon were
used for all subsequent experiments to insure that the PKR activation observed was due to the
infection. Consistent with the higher number of SG-positive cells in W956IC-infected BHK
cultures, higher levels of activated PKR (phosphorylated at Thr451) and phosphorylated eIF2α
would also be expected in these cultures compared to WNV Eg101-infected cultures. Cell lysates
collected at various times after infection with WNV Eg101 or W956IC were analyzed by
Western blotting for total and phosphorylated PKR and eIF2α. PKR phosphorylation was not
detected in any of the WNV Eg101-infected lysates; however, phosphorylated PKR was detected
in the W956IC samples from 16 through 28 hr after infection (Figure 3.4A). eIF2α
phosphorylation in W956IC-infected cells was detected starting at 16 hr after infection (Figure
3.4A). Because a more sensitive Western blot detection system was used in this study than in our
previous study (Emara and Brinton, 2007), some phosphorylated eIF2α was detected at 24 and
28 hr after infection with WNV Eg101. In contrast, similar levels of total eIF2α were detected by
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Figure 3.4. W956IC-infected cells have elevated levels of phosphorylated PKR and eIF2α.
(A) Western blot analysis of BHK cells infected with WNV Eg101 or W956IC at a MOI of 1.
Lysates were collected in RIPA buffer at the indicated times after infection and analyzed using
antibodies specific for the detection of phosphorylated PKR (Thr541), PKR, phosphorylated
eIF2α (Ser51), eIF2α, and actin. (B) BHK cells were infected with WNV Eg101 or W956IC at a
MOI of 1, fixed at 24 hr after infection and analyzed by confocal microscopy. Anti-G3BP
antibody (green) was used to detect SGs and anti-p-eIF2α antibody (white) to detect p-eIF2α.
More than 95% of the cells were infected.
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16 hr after infection with either virus. The increase in eIF2α phosphorylation in the Eg101infected cells in the absence of PKR phosphorylation suggested that it was due to the activation
of another eIF2α kinase. The increase in phosphorylated eIF2α at later times of infection
correlated with the increase in SG-positive, WNV Eg101-infected BHK cells from <1% at 24 hr
to <3% at 36 hr after infection.
To determine whether SG-positive, infected cells contained elevated levels of
phosphorylated eIF2α, BHK cells were infected with WNV Eg101 or W956IC, fixed at 24 hr
after infection and analyzed by confocal microscopy. The level of p-eIF2α was high in all cells
that were SG-positive (Figure 3.4B). However, not all p-eIF2α-positive cells contained SGs (data
not shown) suggesting that there may be a threshold level of p-eIF2α needed for SG induction or
that additional cell factors/conditions may also be involved in SG formation.

Mapping the viral determinants involved in enhanced SG induction by W956IC virus
infection
The W956IC cDNA plasmid is very stable in bacteria and has been a useful tool for
recovering WNV genomes with engineered mutations (Basu and Brinton, 2011). The W956IC
cDNA was constructed from a highly passaged WNV B956 virus stock designated 956D117B3
(Yamshchikov et al., 2001). The 956D117B3 sequence differs from that of B956 by 32 single nt
substitutions within the coding region (Yamshchikov et al., 2004; Yamshchikov et al., 2001).
Although 956D117B3 cDNA was used to construct the majority of the W956IC infectious clone,
the C-terminus of the NS5 gene through the 3′ UTR region was amplified from WNV Eg101
genomic RNA (Yamshchikov et al., 2001). To identify viral components associated with less
efficient SG induction, additional chimeric W956IC genomes were made by replacing one or
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Figure 3.5. Schematic representation of the WNV W956IC-Eg101 chimera genomes. Eg101
sequences are shown in grey and W956IC sequences are shown in blue. The majority of the
W956IC genome sequence is from D117B956 but the C-terminus of NS5 and the 3′ UTR are
from Eg101. Additional chimeric viruses were created by replacing one or more W956IC genes
with the Eg101 equivalent on the W956IC backbone.
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more W956IC genes with the Eg101 equivalent as described in the Materials and Methods. Eg-C
(capsid), Eg-NS1, Eg-NS2a, Eg-NS3+4a, Eg-NS4b, Eg-NS5, Eg-NS1+3+4a, and Eg-NS1+5
chimeric viruses were constructed (Figure 3.5). All of the chimeric WNV infectious clones
constructed contained the 3′ UTR from Eg101 and all but the Eg-NS5 and Eg-NS1+5 clones
contained the 956D117B3/Eg101 hybrid NS5 gene.
BHK cells were infected with one of the chimeric viruses, fixed at 36 hr after infection
and analyzed for SGs by confocal microscopy. Consistent with the data shown in Figure 3.1,
WNV Eg101 infections induced SGs in <3% of infected cells while W956IC infections induced
SGs in ~30% of the infected cells at 36 hr after infection (Figure 3.6A and B). The Eg-NS1
(~7%), Eg-NS2a (~15%), Eg-NS3+4a (~8%), Eg-NS4b (~10%), and Eg-C (~20%) chimeric
virus infections induced intermediate numbers of SG-positive, infected cells by 36 hr after
infection, while the Eg-NS5 (<3%), Eg-NS1+3+4a (<3%), and Eg-NS1+5 (<3%) chimeric virus
infections induced few SG-positive, infected cells similar to Eg101 infections (Figure 3.6A and
B). The data indicate that either the replacement of the N-terminal region of NS5 or of the NS1,
NS3 and NS4a genes with Eg101 sequence recreated the WNV Eg101 SG phenotype.
The growth kinetics of the various chimeric viruses was analyzed to determine whether
the differential SG phenotypes were due to differences in the growth efficiencies of these
viruses. BHK cells were infected with WNV Eg101, W956IC or one of the chimeric viruses at a
MOI of 1 and culture fluid was collected at various times after infection. Eg101 and W956IC
infections produced similar virus yields at 24 and 36 hr after infection (Figure 3.6C). However,
W956IC infections produced significantly more progeny virus than Eg101 infections at 12 hr
after infection (Figure 3.6C). The yields produced by Eg-C, Eg-NS1, Eg-NS2a, Eg-NS3+4a, and
Eg-NS4b chimeric virus infections at 12 hr were similar to that produced by a W956IC infection,
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while the 12 hr yields from Eg-NS5, Eg-NS1+3+4a, and Eg-NS1+5 infections were comparable
to that from an Eg101 infection (Figure 3.6C). Virus yields from the Eg-C, Eg-NS1, Eg-NS2a,
Eg-NS3+4a, and Eg-NS4b chimeric virus infections at 24 and 36 hr were similar to those of both
the Eg101 and W956IC infections (Figure 3.6C). However, the Eg-NS5 and Eg-NS1+3+4a
chimeric virus infections produced slightly reduced virus yields at 24 and 36 hr after infection.
Although the yield of Eg-NS1+5 virus was slightly decreased at 24 hr, levels comparable to
Eg101 and W956IC virus infections were observed by 36 hr (Figure 3.6C). These data indicate
that the replication efficiencies of none of the chimeric viruses were significantly compromised.
Since PKR is activated by double stranded regions of viral RNA (Garcia et al., 2007), the
levels of intracellular viral plus strand RNA produced by Eg101, W956IC and the chimeric
viruses early after infection was next assessed. BHK cells were infected with WNV Eg101,
W956IC or a chimeric virus at a MOI of 1 and total cellular RNA was collected at 12 hr after
infection. The number of viral genome copies per 1 µg of total RNA was quantified as described
in the Materials and Methods. Consistent with the 12 hr viral yields, W956IC infections
synthesized the highest levels of viral RNA by 12 hr after infection while Eg101 infections
synthesized the least (Figure 3.6D). The Eg-C, Eg-NS1, Eg-NS2a, Eg-NS3+4a and Eg-NS4b
chimeric virus infections produced higher levels of early intracellular viral RNA like a W956IC
infection, while the Eg-NS5, Eg-NS1+3+4a, and Eg-NS1+5 infections produced lower levels of
early viral RNA similar to an Eg101 infection (Figure 3.6D). The results indicate that more
efficient SG induction in infected cells correlates with increased levels of viral RNA synthesis at
early times after infection. The data further suggest that interaction between viral nonstructural
proteins and possibly also between nonstructural proteins and viral RNA and/or cell proteins are
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Figure 3.6. The levels of early viral RNA synthesis correlate with the level of SG-positive,
infected cells and virus yield. (A) BHK cells were infected with the indicated WNV chimeric
virus at a MOI of 1, fixed at 36 hr after infection and analyzed by confocal microscopy. SGs
were detected with anti-G3BP antibody (green), WNV-infected cells with anti-dsRNA antibody
(red), and nuclei with Hoechst dye (blue). Merged images are shown. (B) Total and SG-positive,
infected cells were counted and the percentage of infected cells containing SGs was determined.
* - Significance compared to W956IC was determined at a 95% confidence interval (p < 0.05).
(C) BHK cells were infected with the indicated chimeric virus at a MOI of 1 and the virus yield
was determined by plaque assay. (D) BHK cells were infected with the indicated chimeric virus
at a MOI of 1 and total RNA was extracted and purified at 12 hr after infection. The number of
viral genome copies in each sample was determined using probes targeting the viral NS1 gene as
described in the Materials and Methods. (E) To determine the accuracy of loading, the amount of
GAPDH RNA in each sample was measured to show that the same amount of total RNA was
used throughout the experiment. Error bars indicate standard deviation of the mean.
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involved in suppressing early viral RNA synthesis more effectively in cells infected with natural
WNV strains.

Enhanced early viral RNA synthesis in W956IC-infected cells results in cytoplasmic
exposure of viral dsRNA
Viral dsRNA in infected cells is sensed by the pathogen recognition receptors (PRRs),
PKR, retinoic acid inducible gene I (RIG-I) and melanoma differentiation factor 5 (MDA5)
(Garcia et al., 2007; Kato et al., 2008). Flavivirus dsRNAs are thought to evade detection by cell
RNA sensors by localization within ER membrane vesicles (Overby et al., 2010). It was
previously reported that treating cells with 0.01% Triton X-100 permeabilizes the plasma
membrane but leaves the intracellular ER membranes intact while 0.1% Triton X-100 solubilizes
both plasma and ER membranes (Mertens et al., 2010). Differential membrane permeabilization
was used to assess viral dsRNA membrane association at early times after infection. BHK cells
were infected with WNV Eg101 or W956IC at a MOI 5 and permeabilized with either 0.1% or
0.01% Triton X-100 at 12 hr after infection. After fixation and differential permeabilization, the
cells were analyzed for the presence of viral dsRNA and SGs by confocal microscopy. Viral
dsRNA was detected in the majority of Eg101- and W956IC-infected cells permeabilized with
0.1% Triton X-100 (Figure 3.7A). In contrast, after permeabilization with 0.01% Triton X-100,
viral dsRNA was detected in ~25% of the W956IC-infected cells but in only ~4% of the Eg101infected cells (Figure 3.7B). Similar to what was seen with the experiments quantifying SGpositive, infected cells, W956IC infections produced a higher number of cells with detectable
dsRNA compared to Eg101 infections (Figure 3.7A). The higher percent of infected cells with
detectable dsRNA with the 0.01% Triton X-100 treatment was likely due to the use of a MOI of
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Figure 3.7. Exposed viral dsRNA was detected in 0.01% Triton X-100 permeabilized W956ICinfected but not Eg101-infected cells. (A) BHK cells were infected with WNV Eg101 or
W956IC at a MOI of 5, fixed at 12 hr after infection, permeablized with either 0.1% or 0.01%
Triton X-100 and analyzed by confocal microscopy. Anti-dsRNA antibody (red) was used to
detect viral dsRNA, anti-G3BP (green) to detect SGs, and Hoechst dye (blue) to detect nuclei.
Merged images are shown. (B) The total number of cells and the number of dsRNA signalpositive cells from 0.01% Triton X-100-treated cells were counted and the percentage of cells
containing detectable dsRNA was determined.
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5 instead of 1. Importantly, these data also showed that the W956IC-infected cells that contained
elevated levels of exposed viral dsRNA also contained SGs (Figure 3.7A), suggesting that when
viral dsRNA is not protected by cytoplamic membranes, it can activate PKR leading to eIF2α
phosphorylation and SG formation. Why high levels of early viral RNA are produced in a few of
the WNV Eg101-infected BHK cells and why a maximum of ~20-30% of W956IC-infected cells
have high levels of early viral RNA is currently not known and suggest that additional cell
factors may also be involved in the regulation early viral RNA synthesis levels.

DISCUSSION
The cytoplasmic PRR, PKR, is activated by viral dsRNA. Activated PKR phosphorylates
Ser51 of eIF2α which attenuates cap-dependent translation and usually leads to the formation of
SGs. Because the WNV genome is capped, its translation would be expected to be inhibited by
eIF2α phosphorylation. In contrast, members of other flavivirus genera, such as pestiviruses and
hepatitis C viruses, initiate translation from an IRES and their translation would not be expected
to be affected by eIF2α phosphorylation (Robert et al., 2006). Another reason why flavivirus
infections would benefit from not inducing the formation of SGs is our previous finding that the
SG-nucleating proteins TIA-1 and TIAR facilitate plus-strand viral RNA synthesis (Emara and
Brinton, 2008; Li et al., 2002). Infections with viruses have previously been reported to induce
SGs through PKR activation but only in a subset of the infected cells (Hanley et al., 2010;
Lindquist et al., 2011b; Venticinque and Meruelo, 2010). Infections with natural lineage 1 and
lineage 2 strains of WNV did not activate PKR but infections with the chimeric W956IC virus
did and SG induction by W956IC virus infections was shown to be dependent on PKR. Similar
to our findings with WNV, infections with a respiratory syncytial virus (RSV) chimeric virus
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(LeC) induced a higher number of SG-positive, infected cells than natural RSV strain infections
through the activation of PKR (Groskreutz et al., 2010; Hanley et al., 2010; Lindquist et al.,
2011a; Lindquist et al., 2011b). Although many types of viruses have evolved mechanisms to
inhibit PKR activation (Garcia et al., 2007), a previous study from our lab showed that WNV
Eg101 infections do not actively inhibit PKR activation but instead do not activate PKR
(Elbahesh et al., 2011b). The slight increase in SG-positive, Eg101-infected cells observed at
later times of infection (from ~1% at 24 hr to ~3% by 36 hr) could be caused by PERK activation
due to induction of an unfolded protein response (UPR). Natural WNV infections were
previously reported to induce the UPR at later times of infection (Ambrose and Mackenzie,
2011). The UPR can activate PERK, another of the eIF2α kinases. Activated PERK was
previously detected in WNV-infected cells at later times of infection (Ambrose and Mackenzie,
2011).
The chimeric junction in the W956IC genome produces a 956D117B3/Eg101 hybrid
NS5. This hybrid NS5 did not cause a reduction in the replication efficiency of the W956IC virus
since the yields from Eg101 and W956IC infections were comparable at 24 to 36 hr. In fact, the
chimeric W956IC virus synthesized RNA more efficiently at early times after infection than did
Eg101. The increased levels of early viral RNA synthesis observed in W956IC-infected cells
correlated with an increase in PKR activation and SG formation. The replication of flavivirus
RNA in infected cells was previously reported to be biphasic (Chu and Westaway, 1985; Cleaves
et al., 1981). Genomic and complementary minus strand RNAs are replicated symmetrically at
low levels until about 10 to 12 hr after infection. Thereafter, RNA replication increases
exponentially and is asymmetric with genome RNA synthesis predominating. The exponential
increase in viral RNA replication occurs after sufficient virus-induced proliferation and
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rearrangement of ER membranes has occurred (Lindenbach, 2007). Flavivirus infections as well
as some other positive-sense RNA virus infections form vesicles in ER membranes that serve as
the sites of exponential viral RNA synthesis and viral nonstructural proteins have been reported
to be involved in cytoplasmic membrane remodeling (den Boon and Ahlquist, 2010; Gillespie et
al., 2010; Welsch et al., 2009). These vesicles open to the cytoplasm through a small pore and
data from several studies suggest that these vesicles protect viral dsRNA from detection by
cytoplasmic sensors (den Boon and Ahlquist, 2010; Gillespie et al., 2010; Overby et al., 2010;
van Hemert et al., 2008; Welsch et al., 2009).
How flavivirus RNA replication is differentially regulated during the early and late
phases of viral RNA synthesis is not known. It was previously shown that cyclization of the
genome through basepairing between 3′ and 5′ RNA sequences was required for RNA replication
(Basu and Brinton, 2011; Hahn et al., 1987; Zhang et al., 2008). Even though in the chimeric
W956IC genome, the 3′ cyclization, DAR and UAR sequences were from Eg101 and the 5′
cyclization, DAR and UAR sequences were from W956, the long distance 5′-3′ basepairing
interactions were completely conserved (data not shown). It has also been reported that the WNV
5′ UTR interacts with the NS5 protein, which contains the methyltransferase and RNAdependent RNA polymerase domains. Alteration of this RNA-protein interaction dramatically
affected the replication efficiency of WNV (Dong et al., 2008). The WNV Eg101 and W956IC 5′
UTRs only differ by 1 nt located in a position that was not previously shown to be involved in
the interaction with NS5, suggesting that this substitution would not affect viral RNA replication
efficiency. It is possible that the viral nonstructural protein complexes assume different
conformations during the early and late phases of viral RNA replication. Replication complex
conformations could be mediated by interactions with different cell partners and/or different
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cellular membrane microenvironments. The three WNV chimeras that displayed both low levels
of early viral RNA synthesis and SG induction similar to Eg101 were Eg-NS5, Eg-NS1+3+4a
and Eg-NS1+5. The polyprotein sequences of Eg101 and W956IC were aligned and revealed a
number of amino acid changes in the nonstructural proteins as there are 32 aa changes in NS1, 30
aa changes in NS3+4a, and 33 aa changes in NS5. The majority of these mutations are within the
same class and are unlikely to modify the function of these proteins. These analyses identified
five mutations within NS1, NS3+4a and NS5 that are unique to W956IC and D117B956
compared to the various WNV strains tested and are currently being tested for their effect on
early viral replication efficiency and SG induction. However, it is more likely that the difference
in replication efficiencies between these viruses is due to a combination of mutations and not to a
sole residue mutation as evidenced by the lack of a single viral protein causing the difference in
SG induction. The finding that chimeras with either an NS5 with both its N- and C-terminal
regions from Eg101 or a combination of the Eg101 NS1, NS3 and NS4a proteins produced low
levels of early viral RNA synthesis support the hypothesis that viral nonstructural protein
conformations and interactions within replication complexes play a role in down-regulating RNA
synthesis early during natural WNV infections. Similarly, a previous study mapping flavivirus
nonstructural proteins involved in inhibiting IFN signaling also did not identify a single protein
as the cause for the difference and further supports the findings of the present study (Ambrose
and Mackenzie, 2011).
It is currently not known how viral dsRNA is protected from cytoplasmic RNA sensors
during early low level symmetric viral RNA synthesis. The results of the present study indicate
that essentially all of the viral dsRNA present at 12 hr in the majority of Eg101-infected cells
was associated with cytoplasmic membranes, while some of the dsRNA in ~25% of W956IC
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virus-infected cells was not. This finding suggests that natural strains of WNV are able to
carefully match the level of RNA replication with the degree of cytoplasmic membrane
remodeling. When this coordination is dysregulated, such as in W956IC-infected cells, higher
levels of early RNA replication exceeds the capacity of the available virus-induced membrane
protection exposing some of the viral dsRNA and results in PKR activation, eIF2α
phosphorylation and SG formation.

MATERIALS AND METHODS
Cells
All cell lines used were maintained at 37ºC in 5% CO2. Baby hamster kidney 21 strain
W12 (BHK) cells (Vaheri et al., 1965) and a C3H/He mouse embryo fibroblast (MEF) cell line
(Scherbik et al., 2006) were maintained in minimal essential medium (MEM) supplemented with
5% heat-inactivated fetal bovine serum (FBS), glutamine, and 10 µg/ml gentamicin. C57BL/6,
PERK+/+, PKR-/-, PERK-/-, GCN2-/-, and HRI-/- MEFs were maintained in Dulbecco’s Modified
Eagle Medium (DMEM) supplemented with 10% FBS, glutamine, and 10 µg/ml gentamicin. The
PERK-/-, GCN2-/-, and HRI-/- cells are all allelic knockouts, whereas the PKR-/- cells express a
nonfunctional PKR due to a deletion of the RNA-binding domain found in exons 2-4 (Yang et
al., 1995). The PERK+/+, PERK-/-, GCN2-/- and HRI-/- MEFs were provided by David Ron (New
York University School of Medicine, New York, NY) and the PKR-/- MEFs were provided by
Robert Silverman (Lerner Research Institute, Cleveland Clinic, Cleveland, OH).
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Viruses
WNV Eg101 and W956IC were prepared by infecting BHK cell monolayers at a
multiplicity of infection (MOI) of 0.1 and harvesting culture fluid at 32 hr after infection.
Clarified culture fluid was aliquoted and stored at -80ºC. Aliquots of WNV NY99, Tx113, B956,
Mg78 and SPU were provided by Robert Tesh (University of Texas Medical Branch, Galveston)
and stocks were grown in BHK cells as described for Eg101. Titers of the virus stocks were:
Eg101 1x108; W956IC 5x107; NY99 1x108; Tx113 5x107; B956 1x107; Mg78 3x106; and SPU
7x107. Virus infectivity was assessed by plaque assay on BHK monolayers as previously
described (Scherbik et al., 2007b).

Construction of chimeric viruses
The construction of the 956D117B3/Eg101 infectious clone SP6WNEg3′/Xba, here
referred as W956IC, was described previously (Yamshchikov et al., 2001). The capsid, NS1,
NS2A, NS3-NS4A, NS4B, NS5 lineage 2 genes or combinations of these genes were replaced in
the W956IC backbone with the corresponding lineage 1 genes from Eg101. RNA was purified
from WNV Eg101 and specific cDNA fragments were obtained by RT-PCR amplification using
specific primers and the SuperScript® One-Step RT-PCR System with Platinum® Taq DNA
Polymerase (Invitrogen). The primers were designed based on the Eg101 sequence (GenBank#
AF260968). Nt changes, that did not alter the amino acid sequence, were included in some
primers to introduce unique restriction sites present in the W956IC sequence. The nt coordinates
indicated below are from the 956D117B3 sequence (GenBank# M12294). To create a W956IC
chimera with a capsid gene from Eg101 (Eg-Cap), a fragment containing two unique BglII sites
(89-465 nts) was amplified from Eg101 RNA and a fragment containing two MfeI sites (465-918
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nts) was amplified from W965IC, a BglII-MfeI fragment was obtained by overlapping PCR and
cloned into W956IC. Additional chimeras were created by amplifying the following fragments
from Eg101 RNA and cloning them into W956IC: Eg-NS1, a MunI (nt 2393) - NsiI (nt 3513)
fragment; Eg-NS2a, a NsiI (nt 3513) - BstB1 (nt 5135) fragment; Eg-NS3+4a, a BstB1 (nt 5135)
- SphI (nt 6777) fragment; Eg-NS4b, a SphI (nt 6777) - FseI (nt 7021) fragment; and Eg-NS5, a
FseI (nt 7021) - AvrII (nt 8901) fragment. For the Eg-NS1+3+4a chimera, a MunI (nt 2393) NsiI (nt 3513) fragment was amplified from Eg101 and cloned to the Eg-NS3+4a chimera and
for the Eg-NS1+5 chimera, a MunI (nt 2393) - NsiI (nt 3513) fragment was amplified from
Eg101 and cloned into the Eg-NS5 chimera. All of the chimeric clones were validated by
sequencing. The sequences of the primers used in this study are available upon request.

Confocal Microscopy
Confocal microscopy was performed as previously described (Emara and Brinton, 2007).
Virus-infected cells were detected with anti-dsRNA antibody (English & Scientific Consulting;
Szirak, Hungary). SGs were detected with anti-G3BP (Ras-GAP-SH3-binding protein) (Abcam
and Sigma Aldrich). Anti-Dcp1a antibody (a gift from J. Lykke-Anderson; University of
Colorado, Boulder, CO) was used to detect PBs. AlexaFluor 350-, AlexaFluor 488-, or
AlexaFluor 594-labeled secondary antibodies (Invitrogen) were diluted in blocking buffer
containing 0.5 µg/ml Hoechst 33258 dye (Molecular Probes, Bedford, MA) to detect nuclei.
Images were taken using a LSM 510 confocal microscope (Zeiss, Oberkochen, Germany) with
either a 63x water-immersion or 100x oil-immersion objective. Images were analyzed with Zeiss
LSM Image Browser software.
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SG-Postive Infected Cell Quantification
A wide-field immunofluorescence microscope with a 40x objective was used to acquire
images of large fields of WNV-infected cells stained with anti-dsRNA antibody to detect
infected cells and anti-G3BP to detect SG-positive, infected cells at the indicated times after
infection and/or treatment. The percentage of SG-positive, infected cells was calculated. 100
cells per field, from four or more fields of view per treatment, were counted. Quantification was
done on cells from three separate experiments and statistical significance was determined at a
95% confidence interval.

Quantification of viral RNA
In vitro transcribed viral genome RNA of a known concentration was serially diluted and
used to generate a standard curve (y = -0.2472x + 10.751, where “x” represents the cycle
threshold (CT)) by real time RT-PCR. This standard curve was then used to determine the
absolute amount of viral RNA in each cell extract sample. BHK cells were infected with a strain
of WNV at a MOI of 1 and lysed 12 hr after infection. Total cell RNA was purified using
TriReagent (Molecular Research Center) according to the manufacturer’s protocol and quantified
by spectophotometry at OD260. The mean CT value for each RNA sample was determined by real
time RT-PCR using a probe targeting the WNV NS1 gene. The mean CT value was plotted on
the standard curve to estimate the number of viral genome copies per 1 µg of total RNA in each
cellular extract.
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Western blotting
Western blot analyses were performed as previously described (Scherbik et al., 2006).
Primary antibodies include: anti-p-PKR (T451) (Millipore), anti-PKR (SCBT), anti-p-eIF2α
(Ser51), anti-eIF2α (Cell Signaling), anti-NS3 (R&D Systems), and anti-actin (Abcam). The
secondary antibodies included anti-rabbit-HRP, anti-mouse-HRP (Cell Signaling), and anti-goatHRP (SCBT). All antibodies were diluted in 5% NFDM except for p-PKR and p-eIF2α, which
were in 5% BSA.

Plaque Assay
Virus yields were determined as previously described (Scherbik et al., 2007b).

MTT Assay
Confluent monolayers in 96-well plates were infected with W956IC at a MOI of 1. Virus
was adsorbed for 1 hr at room temperature and the cells were then incubated in fresh media
containing different concentrations of 2-aminopurine (2-AP) or DMSO (solvent control) for 24
hr at 37ºC in 5% CO2. A CellTiter 96® non-radioactive cell proliferation assay was the done
according to the manufacturer’s protocol (Promega).

86
ADDITIONAL DATA
Previous work in the lab showed that WNV Eg101 and dengue 2 virus infections did not
induce the formation of SGs but inhibited the formation of SGs by oxidative stress (i.e. arsenite
treatment) (Emara and Brinton, 2007). None of the natural lineage 1 or lineage 2 WNV strains
tested induced SG formation in infected cells, but that W956IC infections did (Figure 3.1). The
ability of these additional natural WNV strains and W956IC infections to inhibit the formation of
arsenite-induced (HRI-mediated) SGs was also tested. BHK cells were infected with WNV
Eg101, NY99, Tx113, W956IC, B956, Mg78 or SPU at a MOI of 1, treated with 0.5 mM
arsenite for 30 min prior to fixation at 17 or 24 hr, and analyzed by immunofluorescence. SGs
were detected in each of the WNV strains at 17 hr after infection (Figure 3.8A) and was
consistent with previously published data suggesting that the ability of SG inhibition was less
efficient at earlier times of a WNV infection (Emara and Brinton, 2007). Similar to Eg101,
infections with each natural WNV strain tested were able to inhibit the formation of SGs by
arsenite treatment at 24 hr after infection (Figure 3.8B and C). This was also the case for
W956IC infections that normally induce higher numbers of SG-positive cells. For each virus
strain tested, the inhibition of SGs at 17 hr after infection was less efficient (Figure 3.8A). These
results suggest that the ability of WNV strains to inhibit arsenite-induced SG formation increases
with time after infection.
PERK has been reported to be activated by the treatment of cells with dithiothreitol
(DTT) which causes unfolded proteins to accumulate in the ER and leads to the unfolded protein
response (Liang et al., 2006). To confirm that DTT treatment induces the formation of SGs,
BHK cells were treated with 1 mM, 2 mM or 10 mM DTT for 30 min or 60 min prior to fixation
and analyzed for SGs by immunofluorescence. The 2 mM and 10 Mm DTT concentrations
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Figure 3.8. The effect of infections with various WNV strains on arsenite-induced, HRImediated SG formation. BHK cells were infected with individual strains of WNV at a MOI of
1, treated with 0.5 mM arsenite for 30 min starting at 16.5 hr (A) or at 23.5 hr after infection (B),
then fixed and analyzed by confocal microscopy. SGs were visualized using either anti-TIAR
antibody (green) (A) or anti-G3BP antibody (green) (B), WNV-infected cells were visualized
using anti-dsRNA antibody (red), and cell nuclei were visualized with Hoechst dye (blue). (C)
SG-positive, infected cells treated with arsenite were quantified.
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induced higher levels of SGs in BHK cells than 1 mM DTT (Figure 3.9A); however, the 10 mM
DTT treatment for both 30 and 60 min caused increased cytopathic effects. The 30 min 2 mM
DTT treatment induced higher levels of SGs than the 60 min treatment and treatment with this
concentration for 30 min was used for additional experiments. To determine whether WNV
infections could also inhibit the formation of PERK-induced SGs, BHK cells were infected with
individual strains of WNV at a MOI of 1, treated with 2 mM DTT at 23.5 hr for 30 min, then
fixed and analyzed by immunofluorescence. Only B956 infections were found to be able to
inhibit the formation of DTT-induced, PERK-mediated SG formation; SGs were observed in
~15% of B956-infected cells and in ~70% of cells infected with the other WNV strains tested
(Figure 3.9B and C).
Studies were next done to analyze whether natural WNV infections could inhibit PKRinduced SG formation. As presented above, W956IC infections induce the formation of SGs
through the activation of PKR (Figure 3.2). Therefore, BHK cells were infected with W956IC to
induce the activation of PKR during infection and a natural WNV strain to determine whether
the natural strain infections could inhibit PKR-induced SG formation. BHK cells were first
infected with an individual natural WNV strain and then subsequently co-infected with W956IC
30 min later. Both infections were done at an MOI of 5 to increase the likelihood that most cells
would be coinfected with both viruses. Cells were fixed at 24 hr after co-infection and analyzed
by immunofluorescence. SGs were observed in ~20±5% of the infected cells for each WNV
strain co-infected with W956IC, similar to W956IC infections alone, indicating that none of the
WNV strains tested could inhibit the formation of W956IC-induced, PKR-mediated SGs (Figure
3.10).
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Figure 3.9. The effect of various WNV strain infections on DTT-induced, PERK-mediated
SG formation. (A) BHK cells were treated for 30 or 60 min with 1 mM, 2 mM or 10 mM
concentrations of DTT to activate PERK and induce SGs. SG-positive cells were quantified. (B)
BHK cells were infected with individual WNV strains at a MOI of 1, treated with 2 mM DTT for
30 min prior to fixation at 24 hr after infection, and analyzed by immunofluorescence. SGs were
visualized with anti-G3BP antibody (green), WNV-infected cells were visualized with antidsRNA antibody (red), and nuclei were visualized with Hoechst dye (blue). (C) SG-positive,
infected cells were quantified.
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It has been reported that inhibiting the ubiquitin proteasome system with 10 µM MG132
leads to GCN2 activation and SG formation (Mazroui et al., 2007). However, no SGs were
observed in preliminary experiments with this treatment in BHK cells; therefore, it could not be
determined whether WNV infections could inhibit the formation of GCN2-induced SGs. It has
been suggested that UV treatment of cells can also induce the formation of SGs through GCN2
activation; however, experiments testing this treatment have not yet been done. More work is
required to determine whether infections with natural WNV strains are capable of inhibiting
GCN2-mediated SG formation.
Heat shock is another stress known to induce the formation of SGs (Grousl et al., 2009;
Piotrowska et al., 2010); however, the mechanism of heat shock-induced SG formation in
mammalian cells is unknown. In yeast cells, heat shock also induces the formation of SGs.
GCN2 is the only known eIF2α kinase in yeast but gcn2Δ yeast cells treated with heat shock still
induced the formation of SGs suggesting that SG formation by heat shock treatment is
independent of eIF2α phosphorylation (Grousl et al., 2009). To determine whether WNV
infections can inhibit the formation of SGs by heat shock, BHK cells were infected with different
WNV strains at a MOI of 1 for 24 hr, incubated at 45⁰C for 20 min, then fixed and analyzed for
SGs by immunofluorescence. None of the WNV strain infections tested inhibited heat shockinduced SGs (Figure 3.11). Overall, the data from these experiments suggest that the ability of
WNV infections to inhibit SG formation is specific to the oxidative stress response pathway.
A preliminary study done by a former member of the lab suggested that the WNV NS5
protein immunoprecipitated with HRI (data not shown). It is possible that WNV infections
specifically inhibit HRI-induced SG formation through the inhibition of either HRI activation or
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Figure 3.10. The effect of various WNV strain infections on W956IC-induced, PKRmediated SG formation. (A) BHK cells infected with an individual natural WNV strain and
then co-infected with W956IC, known to induce PKR-dependent SGs, 30 min later. Each virus
was used at a MOI of 5 to increase the likelihood of co-infection. Co-infected cells were fixed at
24 hr and analyzed by immunofluorescence. SGs were visualized using anti-G3BP antibody
(green), WNV-infected cells were visualized using anti-dsRNA antibody, and nuclei were
visualized using Hoechst dye (blue). Scale bar represents 20 µm. (B) SG-positive, infected cells
were quantified.
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its ability to function as a kinase through an NS5-HRI interaction. To determine whether the
WNV NS5 protein is able to specifically inhibit HRI-induced SG formation, BHK cells stably
expressing WNV NS5 were created. These cells were treated with 0.5 mM arsenite for 30 min,
fixed and analyzed for SG formation by immunofluorescence. The results showed that NS5
protein expression does not inhibit the formation of HRI-induced SGs (Figure 3.12). However, it
has recently been suggested that a functional interaction of the NS5 protein with another cell
protein required in situ protease cleavage from a polyprotein (Ashour et al., 2009). Whether this
may also be the case for NS5-mediated inhibition of HRI-induced SG formation was not tested.
Overall, these data show that the inhibition of SG formation by WNV infection is specific to the
HRI kinase pathway; however, the mechanism of this inhibition is currently under further
investigation. It is interesting that WNV strains do not induce SG formation during infection but
that they actively suppress the formation of SGs specific to oxidative stress. Furthermore, the
efficiency of this suppression increases through the course of infection. It has been reported that
numerous virus infections induce oxidative stress through the formation of reactive oxygen
species or nitric oxide (Akaike and Maeda, 2000; Chen et al., 2009; Hosakote et al., 2009;
Schweizer and Peterhans, 1999; Tardif et al., 2005). It is possible that the inhibition of HRImediated SG formation by WNV infections is a non-specific byproduct of an active inhibition of
the antiviral oxidative stress response pathways by viral components in infected cells.
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Figure 3.11. The effect of various WNV strain infections on heat shock-induced SG
formation. (A) BHK cells were infected with individual WNV strains at a MOI of 1, incubated
at 45⁰C for 20 min prior to fixation at 24 hr after infection, and analyzed for SGs by
immunofluorescence. SGs were visualized using anti-G3BP antibody (green), WNV-infected
cells were visualized using anti-dsRNA antibody (red), and nuclei were visualized using Hoechst
dye (blue). (B) SG-positive, infected cells were quantified.
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Figure 3.12. The effect of WNV NS5 protein expression on arsenite-induced SG formation.
Control BHK cells or BHK cells stably expressing WNV NS5 (BHK-NS5) were left untreated or
treated with 0.5 mM arsenite for 30 min, then fixed and analyzed for SGs by
immunofluorescence. SGs were visualized using anti-G3BP antibody (green) and NS5expressing cells were visualized using anti-V5 antibody (red).
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CHAPTER 4

SIGNIFICANCE/FUTURE DIRECTIONS
Oas1b-Mediated Resistance to Flavivirus-Induced Disease
The majority of the viruses known today were discovered because of a disease they
caused in an infected host. Advances in technology and therapeutics have substantially improved
the ability to control viral infections. However, natural genetically-mediated host resistance or
susceptibility to infectious viruses has been described in both mice and humans (Lee et al.,
2003). One example of the alleles of a single gene conferring resistance or susceptibility to
disease is Flvr, which was shown to confer resistance to flavivirus-induced disease (Webster and
Clow, 1936; Webster and Johnson, 1941). The product of Flvr was identified as Oas1b, a
member of the antiviral oligoadenylate synthetase gene family (Mashimo et al., 2002; Perelygin
et al., 2002). However, additional studies showed that the products of both the resistance and
susceptibility alleles were inactive synthetases and therefore the specific anti-flaviviral activity
of Oas1b was not mediated by OAS synthetase activation of RNase L (Elbahesh et al., 2011a;
Scherbik et al., 2006). The work of the current study was aimed at identifying interaction
partners of Oas1b as a means of gaining insights about the mechanism of the Oas1b-mediated
anti-flavivirus activity. To our knowledge, this study is the first to identify host cell binding
partners of Oas1b.
One of the binding partners identified was ORP1L, a member of an oxysterol binding
protein family. It was expected that if ORP1L acted as an antiviral protein, then knocking down
the levels of this protein would result in an increase in extracellular WNV yield and intracellular
viral RNA and protein levels; however, a decrease was observed in WNV yield and viral RNA
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and protein levels. Also, decreases were observed in both SinV and VSV yields, suggesting that
this proviral effect was not specific to flaviviruses. However, it was previously reported that the
reduction of ORP1L protein levels increased LE motility (Rocha et al., 2009; Vihervaara et al.,
2011). Each of the viruses showing reduced replication when ORP1L was knocked down utilize
the host endocytic pathway to enter cells (Chu and Ng, 2004; Lu et al., 1999; Superti et al., 1987)
and increased LE mobility could negatively affect the efficiency of virion entry and fusion by
endocytosis. As an additional means of showing that the effect of ORP1L knockdown is not
specific to the flavivirus resistance mechanism, the effect of ORP1L knockdown on the
replication of viruses that do not use the endocytic pathway for entry (i.e. vaccinia virus) could
be tested.
It was previously reported that overexpression of ORP1L causes clustering of LEs near
microtubule organizing centers (Rocha et al., 2009; Vihervaara et al., 2011). ORP1L could be
overexpressed in future experiments to compare the effect on WNV replication in cells
expressing Oas1b or Oas1bt. If overexpression of ORP1L leads to a decrease in the efficiency of
WNV infection in both susceptible Oas1bt-expressing and resistant Oas1b-expressing cells, this
would indicate a non-specific effect of LE clustering which could be analyzed further by
confocal microscopy using anti-Rab7 antibody to detect LEs. Rab7 was previously shown to
extensively colocalize with LEs and to interact with ORP1L (Johansson et al., 2005; Rocha et al.,
2009). Alternatively, overexpression of ORP1L could enhance the specific flavivirus resistance
mechanism since the slowed movement and clustering of LEs in the perinuclear region of cells
(the preferred site of WNV replication processes) might enhance the ORP1L-Oas1b interaction.
If this is the case, cells overexpressing ORP1L and Oas1b would provide a good model for
further studies of the involvement of ORP1L in the flavivirus resistance mechanism. To further
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determine the flavivirus resistance specificity of the effect of ORP1L overexpression, these cells
could also be infected with SinV or VSV. The replication of neither of these viruses would be
expected to be affected if the effect is specific to the flavivirus resistance mechanism. If both
reducing and increasing ORP1L protein levels causes non-specific effects on LE function, then
other techniques will be needed to analyze the involvement of ORP1L in the flavivirus resistance
mechanism.
The other Oas1b interaction partner identified was ABCF3. ABCF3 was shown to
mediate WNV-specific antiviral activity. Even though Oas1b was present, WNV replicated to
higher levels when ABCF3 protein levels were reduced, suggesting that the specific antiflaviviral activity of Oas1b depends on the presence of ABCF3. Also, the antiviral activity of
ABCF3 required the presence of Oas1b, further confirming that the Oas1b-mediated flavivirus
resistance mechanism involves ABCF3. Currently, nothing is known about the cellular functions
of the ABCF3 protein except that it belongs to the F subfamily of the superfamily of ATPbinding cassette-containing proteins. Canonically, these proteins are involved in the transport of
substrate across membranes but the subfamily E and F members lack the typical transmembrane
domains required for translocation of substrates across membranes (Hollenstein et al., 2007;
Locher, 2009). Members of the E and F subfamilies have also been shown to bind translation
initiation factors and have been suggested that to be involved in regulating protein synthesis
(Chen et al., 2006; Kerr, 2004; Paytubi et al., 2008; Tyzack et al., 2000). Interestingly, results
from the current study showed an increase in WNV protein levels, viral RNA and virus yields
when ABCF3 protein levels were reduced, suggesting that the ABCF3 protein may negatively
regulate WNV genome translation. Decreased viral translation would negatively affect both viral
RNA synthesis and virus production. Cellular binding partners of ABCF3 could be identified in
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future experiments as another means of elucidating its normal cell functions and the mechanism
of its anti-flaviviral activity.
Although ABCF3 is normally expressed in cells, its anti-flaviviral function was only
observed when Oas1b was also present. ABCF3 was also shown to interact with Oas1bt and
Oas1a in both yeast two-hybrid and in vitro interaction assays. The main difference between
these Oas1 proteins is their localization within the cell. Oas1b was shown in the present study to
localize to the ER membrane and is the only member of the OAS family of proteins in any
species tested so far found to localize to this compartment of the cell. These data imply that the
interaction between Oas1b and ABCF3 specifically localizes ABCF3 in close proximity to WNV
RNA translation/replication sites. Future studies could investigate whether ER membrane
localization of ABCF3 is required for its antiviral affect. ABCF3 cDNA could be cloned into an
expression vector that fuses a transmembrane ER localization signal to the ABCF3 protein (pERABCF3). The overexpression of this construct in C3H/He (He; Oas1bt-expressing) cells would
be expected to directly localize ABCF3 to the ER membrane. Control He, He-ABCF3 and HeER-ABCF3 cell lines could be created and then infected with WNV and the effect on WNV
yield, viral RNA and viral protein levels determined. It would be expected that He-ABCF3 cells
will produce WNV yields similar to the control cells since Oas1b is not expressed in these cells
and therefore cannot localize ABCF3 to the sites of WNV replication. In contrast, He-ERABCF3 cells might produce reduced viral yields since the ABCF3 protein is localized to the ER
membrane.
Knockdown of ORP1L and of ABCF3 was performed using cells stably expressing
specific shRNAs. However, the levels of these proteins partially recovered during the course of
infection even though no increase in the levels of these proteins is observed with time after
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infection in control cells. These data suggest that WNV infections can inhibit the RNAi pathway.
Other arbovirus infections have been reported to counteract the RNAi pathway in insect cells (Li
and Ding, 2005; Sanchez-Vargas et al., 2009). However, this ability has not been previously
reported for flaviviruses. It is expected that Oas1b-expressing mammalian cells and mice with
ORP1L or ABCF3 gene knockouts would provide better model systems for studying the
involvement of these proteins in flavivirus genetic resistance. However, it should be noted that
ORP1L knockout mice may show disease due to the disregulation of endosomes (Vihervaara et
al., 2011; Yan et al., 2007a).
The results obtained in this study were used to develop a model for the involvement of
the Oas1b-ABCF3-ORP1L complex in flavivirus resistance (Figure 4.1). After attachment of
virion E protein to receptors on susceptible cells (Figure 4.1A), flaviviruses are endocytosed
through clatherin-coated pits (Chu and Ng, 2004). Previous studies reported that cholesterol-rich
membrane microdomains in the plasma membrane are required for WNV entry into cells since
cholesterol-depleted cells failed to internalize WNV particles (Medigeshi et al., 2008).
Acidification of the endosome leads to conformational changes in E and then LE-specific anionic
lipids facilitate E-mediated fusion of the viral envelope and host endosomal membranes and
release of the viral genome (Zaitseva et al., 2010). Movement of LEs along microtubule
networks requires the recruitment of RILP and ORP1L by Rab7 which is located on the outer
surface of LEs. RILP in this complex can interact with the p150Glued subunit of the dyneindynactin motor complex and mediate LE movement towards the center of the cell (Johansson et
al., 2005; Johansson et al., 2007). After the release of the viral genome, endosomes either
continue onto lysosomes for degradation or recycle back to the plasma membrane. Truncated
Oas1b (Oas1bt) binds to ABCF3 but Oas1bt does not properly localize ABCF3 within the cell
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for it to exert its anti-flaviviral activity. The tripartite protein complex of Oas1b, ORP1L and
ABCF3 may be critical to the flavivirus-resistance mechanism. During infection of resistant cells
(Figure 4.1B), LEs move along the microtubule as described above. In resistant cells, full length
Oas1b is inserted in the ER membrane and is bound to ABCF3, providing a specific location for
this antiviral complex within the cell. When LEs move along microtubules and encounter the
ER-bound Oas1b protein, ORP1L interacts with Oas1b, forming a tripartite protein complex with
ABCF3. This complex docks the LE. When fusion of the virion with the LE occurs, the genome
is released near the Oas1b-ABCF3-ORP1L complex, allowing ABCF3 to exert its as yet defined
anti-flaviviral activity. It is proposed that the LE-associated tripartite protein complex would
only affect the initial stages of infection. If Oas1b-ABCF3 protein complexes were always bound
with ORP1L then it would lead to the dysregulation of LEs and thus affect the entry of numerous
viruses that use the endocytic pathway and would not be specific to flaviviruses. However, the
fact that ORP1L and ABCF3 bind different regions of Oas1b suggests that each is involved in
the resistance mechanism. Oas1b-ABCF3 complexes are likely to exist throughout the ER
membrane where they continually act antiviral towards flaviviruses during the course of an
infection. The studies presented here showed that DSP treatment was required for consistent
immunoprecipitation of ORP1L with Oas1b, thus suggesting that this interaction is transient.
WNV infections induce ER membrane proliferation and ORP1L senses membrane cholesterol
and it is possible that the transient interaction of Oas1b with ORP1L provides lipid sensing that
moves these anti-flaviviral protein complexes to regions of virus replication.
It was previously reported that the ORP1L conformation changes depending on the
cellular cholesterol levels (Rocha et al., 2009). Future experiments could be done to determine
the conformation of ORP1L in WNV-infected cells. When cholesterol levels in LEs are high, the
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ORP1L conformation is closed. This is the conformation expected for virion-containing LEs in
infected cells since these LEs are expected to contain elevated levels of cholesterol from
endocytosed cholesterol-rich lipid rafts. Results from the current study showed that Oas1b
interacts with ORP1L under both mock- and WNV-infected conditions; however, ORP1L was
overexpressed in these cells and ORP1L as well as LEs were likely clustered in the perinuclear
area facilitating an interaction with Oas1b on ER membranes. Future studies analyzing the
ORP1L conformation could be done in resistant or susceptible cells to determine whether the
presence of Oas1b affects ORP1L conformation. Also, ORP1L conformation studies could also
be done in mock- and WNV-infected cells to determine whether WNV infections alter the
conformation of ORP1L.
It was hypothesized that the interaction between Oas1b and ORP1L leads to the docking
of LEs but whether this docking is transient or permanent is unknown. Studies have shown that
VAP-A, an ER integral membrane protein, interacts with ORP1L during low cholesterol
conditions. Under these conditions, the ORP1L conformation is open, exposing the FFAT motif
that can interact with VAP-A. This interaction allows VAP-A to remove the p150Glued subunit of
the dynactin-dynein motor complex inhibiting the movement of the LEs (Rocha et al., 2009).
Future experiments could be done to determine whether VAP-A removes p150Glued from motor
complexes in WNV infected resistant cells. Preliminary data indicate that the VAP-A protein
colocalizes with WNV markers in infected cells at the ER membrane, suggesting that VAP-A
may be in the same area as the Oas1b-ABCF3-ORP1L protein complex. The dissociation of the
motor complex by VAP-A could be an additional means by which LE mobility is inhibited in
WNV-infected resistant cells, thus aiding in the manipulation of the host endocytic pathway so
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Figure 4.1. Proposed model of Oas1b-ABCF3-ORP1L protein complex. (A) Susceptible cells
express truncated Oas1b (Oas1bt) that also interacts with ABCF3; however, this complex is not
localized to the correct compartment of the cell to exert a flavivirus-specific antiviral affect. LEs
carrying WNV virions release the viral genome at the ER where translation/replication occurs.
(B) Resistant cells express full length Oas1b that localizes to the ER membrane and forms a
tripartite complex with ABCF3 and ORP1L. Oas1b binding to ORP1L results in virion fusion
occurring within close proximity of the Oas1b-ABCF3-ORP1L complex. Translation/replication
of the viral genome is then exposed to the anti-flaviviral activity of ABCF3. Oas1b-ABCF3
complexes that may transiently interact with ORP1L likely exist throughout the ER where they
continue to provide flavivirus specific antiviral activity during the course of an infection. LE-late
endosome. D-dynein-dynactin motor complex. P-p150Glued subunit of dynactin.
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that the release of the viral genome occurs in close proximity to the anti-flavivirus protein
complexes.

SG Formation During WNV Infections
The current study confirmed that natural WNV infections do not induce the formation of
SGs. However, infections with the W956IC infectious clone virus induce SGs through the
activation of PKR. A previous study showed that natural WNV infections do not activate PKR
(Elbahesh et al., 2011b) and the data presented here suggest that natural WNV infections do not
induce the formation of SGs. It is not known how WNV infections evade detection by host cell
cytoplasmic RNA sensors but data from the current study suggest that infections with natural
WNV strains suppress the level of their early viral RNA synthesis. In contrast, W956IC
infections produce higher early levels of viral RNA. During WNV infection, intracellular,
perinuclear ER membrane vesicles form and are the sites of late exponential viral genome RNA
synthesis (Gillespie et al., 2010; Welsch et al., 2009). However, it is currently not known what
type of membrane microenvironment is induced by flavivirus infections to protect viral RNA
made at early times after infection from cytoplasmic RNA sensors. Previous studies showed that
a low level of symmetric genome and minus strand viral RNA synthesis is maintained prior to
the formation of the vesicle structures that support exponential genome RNA synthesis (Cleaves
et al., 1981). However, W956IC infections do not regulate early RNA synthesis as efficiently and
so produce increased amounts of viral RNA at early times after infection. The data also suggest
that an insufficient number of early membrane microenvironments are present to protect the
increased level of early viral RNA in W956IC-infected cells. Some viral RNA is therefore
exposed in the cytoplasm which leads to PKR activation, eIF2α phosphorylation and SG
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formation. It is likely that the membrane microenvironment protecting viral RNA early in
infection during symmetric viral RNA synthesis differs dramatically from the membrane
microenvironment that protects viral RNA later in the infection cycle when asymmetric synthesis
of the viral plus strand occurs. This study is the first to show a correlation between the extent of
suppression of early RNA replication and induction of the SG response.
The mapping data obtained with chimeric virus genomes showed that either NS5, or a
combination of NS1, NS3 and NS4a, were critical for regulating early viral RNA synthesis and
controlling the induction of SGs. Each of these nonstructural proteins is a critical component of
the WNV replication complex and the specific contacts between them, as well as with the viral
RNA, and possibly other cell proteins, are thought to be important for modulating the efficiency
of viral RNA synthesis (Brooks et al., 2002; Dong et al., 2008; Johansson et al., 2001; Kapoor et
al., 1995). There are 24 aa substitutions in NS1, 22 aa substitutions in NS3+4a, and 29 aa
substitutions in NS5 between the WNV Eg101 and W956IC protein sequences. Future studies
could be done to identify the critical mutation(s) contributing to the suppression of viral RNA
synthesis at early times after infection. Data from these studies would provide insights about how
WNV polymerase function is differentially regulated during the infection cycle.
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